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1. Abstract 
Endothelial cell (EC) migration is an essential process in angiogenesis as ECs sprout from 
preexisting vessels, following chemotactic gradients. However, most of the data obtained 
about EC migration has been acquired in artificial two dimensional (2D) cell culture 
environments. Recent reports showed that migration in fibrillary environments can be 
mimicked by spatial confinement, achieved by micro patterning techniques (Doyle et al. 
2009). In the first part of this work it was investigated whether a model system based on 
linearly structured surfaces allows to draw conclusions about the migration of ECs in 
fibrillary 3D collagen matrices. In order to estimate the cellular behavior of ECs on linearly 
structured surfaces, a comprehensive cell biological analysis was performed. ECs on 
narrow 3 µm wide tracks (also termed 1D in the following) migrated less efficient in 
comparison to ECs on broader tracks in regard to mean velocity, persistence, and run 
velocity. Additionally, ECs in 1D displayed a distinct actin cytoskeleton architecture, 
compressed nuclei, and different orientation of the centrosome in comparison to ECs on 
wider tracks. The frequent directional changes of ECs on narrow tracks were 
accompanied by pronounced membrane blebbing, while migrating and elongated cells 
displayed a lamellipodium as cellular protrusion. This behavior was contractility-dependent 
as both modes were provoked by using Blebbistatin or Calyculin A, respectively. The 
comparison between 1D and 3D migrating cells revealed a striking similarity in actin 
cytoskeleton architecture and in switching between two morphological modes. Cells 
migrating in 3D moved slower but more persistent after Blebbistatin treatment, which was 
likewise the case for cells migrating in 1D. In contrast to this, cells in the 2D system 
migrated faster but less persistent after Blebbistatin treatment. A Rac1 inhibitor used in 
this study showed the tendency to influence the migratory potential similarly in 1D and 3D, 
in contrast to 2D. However, a microtubule disrupting agent displayed different effects in 
1D and 3D. These experiments demonstrated that the 1D system allows to draw 
conclusions about certain aspects of 3D migration. Thus, using this 1D migration system, 
important aspects of 3D migration can be mimicked in a highly controlled setting. 
In the second part of this work, a system for artificial tip cell formation was investigated. 
For the analysis of tip and stalk cells specifically structured surfaces were designed. 
These structures provided areas allowing only a restricted number of cell-cell contacts and 
areas allowing a high number of cell-cell contacts. ECs with a low number of cell-cell 
contacts displayed increased VEGFR2 expression levels in comparison to cells with a 
high number of cell-cell contacts, a phenomenon which was inhibited by using a Notch 
signaling inhibitor. This system will be a useful tool in the future to decipher tip and stalk 
cell competition within a defined cellular population and a defined microscopic frame. 
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2. Introduction 
2.1 Angiogenesis in health and disease 
Angiogenesis is defined as the formation of new blood vessels derived from a preexisting 
vascular network, and plays an important role in physiological processes like tissue 
growth, development, and wound healing (Tonnesen et al. 2000). However, the process of 
angiogenesis gained most attention in medicine and cancer biology due to its important 
role in numerous pathological conditions and its potential as a therapeutic target 
(Folkman 1995; Carmeliet and Jain 2000). Angiogenesis is functionally divided into two 
sub-forms: sprouting angiogenesis (Ribatti and Crivellato 2012) and intussusceptive 
angiogenesis (Makanya et al. 2009). Sprouting angiogenesis is the scientifically more 
examined form of angiogenesis and is defined as the formation of new blood vessels by 
endothelial sprouts from a pre-existing vessel towards a specific stimulus. For the 
formation of sprouts the endothelial cells (ECs) need to fulfill several requirements e.g. the 
degradation of the basement membrane (a thin fibrous layer separating the ECs from the 
connective tissue) via the action of matrix metalloproteases (Davis and Senger 2005), as 
well as the ability of migration and chemotactic orientation (Terranova et al. 1985; 
Lamalice et al. 2007). In contrast to this, intussusceptive angiogenesis is known as the 
formation of blood vessels by the division of a pre-existing vessel into two vessels, a 
process especially important during embryonic development (Djonov et al. 2000; Makanya 
et al. 2009). Importantly, the process of angiogenesis differs from the process of 
vasculogenesis, where new blood vessels are formed upon differentiation of angioblasts, 
endothelial progenitor cells present in the embryo (D’Alessio et al. 2015). However, the 
traditional distinction between these two processes, playing a crucial role in adults or 
embryonic development, respectively, is blurred as endothelial progenitor cells (EPCs) 
have been shown to be important in adult blood vessel formation (Pelosi et al. 2014) and 
might play a role in tumor angiogenesis as well (Spring et al. 2005). 
In general, angiogenesis has gained a high importance by the pioneering work of Judah 
Folkman, who first described angiogenesis as a crucial process for cancer progression 
(Folkman 1971; Folkman 1995). Since then, an extensive search for angiogenesis 
regulators led to the identification of potential targets for anti-vascular treatment in cancer 
and other diseases. The most examined signaling pathway in this process is the vascular 
endothelial growth factor receptor (VEGFR) pathway, which plays a major role in vascular 
regulation (Olsson et al. 2006), and has been assessed to be a promising target for anti-
cancer therapy. Consequently, the first drug approved for anti-angiogenic cancer 
treatment was the humanized monoclonal antibody Bevacizumab, interfering with VEGFR 
2. Introduction 
3 
signaling by binding to its ligand VEGF-A (Glade-Bender et al. 2003; Willett et al. 2004). 
Many other anti-angiogenic drugs were discovered afterwards, e.g. the multi-kinase 
inhibitors Sorafenib and Sunitinib (Gridelli et al. 2007), or the VEGF-neutralizing aptamer 
Pegaptanib (Doggrell 2005). In the following section, an overview about the underlying 
regulatory mechanisms of VEGFR signaling will be given. 
 
2.2 VEGF-receptor signaling 
Vascular endothelial growth factor receptors are members of the receptor tyrosine kinase 
(RTK) superfamily and consist of a pattern of three different receptors in mammals: 
VEGFR1 (Flt-1), VEGFR2 (Flk-1/KDR), and VEGFR3 (FLT4) (Olsson et al. 2006). 
Common to these receptors is a large extracellular domain consisting of up to seven 
immunoglobulin-like domains, a transmembrane domain, a juxta-membrane domain, and 
two intracellular kinase domains (Olsson et al. 2006) [Fig. 2.1]. Ligands binding to these 
receptors are members of the vascular endothelial growth factor (VEGF) family - VEGF-A, 
VEGF-B, VEGF-C, VEGF-D, the placenta growth factor (PLGF), and the corresponding 
splice variants. Every ligand preferentially forms homodimers and possesses diverse 
affinities to the various VEGFRs, reflecting the complexity of VEGFR regulation, which 
provides the ability to influence various essential physiological processes [Fig. 2.1]. Yet, 
the most prominent factor for angiogenesis is VEGF-A, which is strongly upregulated in 
hypoxic tissue due to stabilization of hypoxia-inducible factors (HIFs) (Pugh and Ratcliffe 
2003). The receptor activation itself occurs by binding of VEGF-dimers, leading to 
homo- or hetero-dimerization and subsequent auto-phosphorylation of the receptor 
(Olsson et al. 2006). Subsequently, recruitment of various scaffold and signaling proteins 
is induced, resulting in signal amplification and translation of the signal into an adequate 
biological response. Inactivation of the receptor is mediated through de-phosphorylation 
by the two phosphatases SHP1 and SHP2 (Guo et al. 2000), or by internalization and 
Fig. 2.1 Interaction of 
various VEGF-dimers with 
the three mammal 
members of the 
VEGF-receptor family. 
Receptors consist of several 
immunoglobulin-domains 
(spheres) and two 
intracellular kinase domains 
(cylinders). Arrows indicate 
affinities. Figure adapted and 
modified from Olsson et al. 
2006.  
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degradation of the receptor (Lampugnani et al. 2006). Beside angiogenesis, 
VEGF-receptor signaling plays a role in various embryogenic processes like lymphatic or 
cardiovascular development (Kaipainen et al. 1995; Madonna and De Caterina 2009) 
Additionally, it is important for the stimulation of nitric oxide (NO) production and thus 
vasodilatation via Akt/PKB and eNOS in ECs (Kroll and Waltenberger 1999; Maniatis et al. 
2006). In the following, VEGFR2 signaling in the context of migration and orientation will 
be described in more detail.  
 
2.3 Migration of endothelial cells 
2.3.1 VEGFR2 signaling and Rho GTPases as regulators of endothelial cell motility 
Migration of ECs requires a highly complex orchestration of processes like orientation, 
protrusion, contraction, and adhesion. After sensing motogenic signals, ECs reorient and 
built actin-dependent cellular protrusions (e.g. lamellipodia). Subsequent attachment of 
these protrusion to the respective substrate via integrins, and stress fiber mediated 
contraction of the trailing edge leads to a translocation of the cell body and completion of 
the migration cycle (Sheetz et al. 1999; Lamalice, Le Boeuf, and Huot 2007). ECs are 
attracted to chemotactic stimuli (VEGF, angiopoietins, and other cytokines), haptotactic 
stimuli (Davis and Senger 2005), and mechanotactic stimuli (Song Li et al. 2005). For 
reasons of simplicity, only VEGF as a chemotactic stimulus and thus regulator of 
migration will be described in more detail.  
VEGFR2 activation is the main intrinsic cellular signal transmitting pathway upon a 
VEGF-A stimulus, as VEGFR2 possesses the highest intrinsic kinase activity in 
comparison to the other VEGFRs (Olsson et al. 2006). As described above, receptor 
activation occurs by dimerization and auto-phosphorylation of the receptors at the tyrosine 
residues Y1214, Y1175, and Y951 which are located in protein binding motifs. These 
phosphorylated binding motifs provide docking sites for proteins harboring SH2 
(src homology 2), or PTB (phosphor-tyrosine binding) domains (Olsson et al. 2006). The 
small GTPases of the Rho family (mainly Cdc42, Rac1, RhoA) are key players in EC 
motility and are regulated by VEGFR signaling (among many other regulatory 
mechanisms). In general, they are described as molecular convergence nodes of 
migration as they act as regulators of actin organization, adhesion assembly, and 
contraction (Parsons, Horwitz, and Schwartz 2010). Their regulation via recruitment and 
activation of guanine nucleotide exchange factors (GEFs) and GTPase activating proteins 
(GAPs) is complex. Crosstalk with other pathways (e.g. integrin signaling pathway), and 
also interactions between the individual GTPases of the Rho family among themselves, 
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leads to a close-meshed cellular signaling network. A simplified overview of Rho GTPase 
signaling pathways and their main tasks in actin reorganization is displayed in Fig. 2.2. 
The small GTPase Cdc42 is known to be activated indirectly by VEGFR2 signaling as its 
activation is dependent of phosphorylation at tyrosine residue 1214 (Lamalice et al. 2004). 
The mediators known for Cdc42 activation are the adaptor protein Nck and the kinase Fyn 
(Lamalice et al. 2006). The most critical role of Cdc42 is the formation and regulation of 
filopodia. These thin actin containing protrusions are located in the cells’ leading edge, 
playing an important role in sensing chemotactic stimuli (Mattila and Lappalainen 2008) 
[Fig. 2.2]. Moreover, Cdc42 is essential for the activation of the p38 MAPK signaling 
pathway, which is involved in actin remodeling and stress fiber formation via heat shock 
protein 27 (HSP27) (Huot et al. 1997). Additionally, Cdc42 has been shown to interact 
with members of the PAK protein family being involved in actin cytoskeletal 
reorganization, e.g. through activation of the LIM-kinase (Edwards et al. 1999). 
In contrast to Cdc42, Rac1 is known to be mainly important for the formation of 
lamellipodia and membrane ruffles (Sit and Manser 2011). It has been shown that Rac1 is 
activated by Vav2, a GEF which is recruited to the membrane upon VEGFR2 signaling 
and subsequently phosphorylated and activated by Src, a direct interaction partner of 
VEGFR2 (Garrett et al. 2007). An important effector of Rac1 is WAVE, a member of the 
Wiskott-Aldrich syndrome protein (WASP) family, which regulates the activity of the 
Arp 2/3 complex. This Arp 2/3 complex stimulates actin polymerization by providing new 
Fig. 2.2 Schematic and simplified overview of Rho GTPase signaling upon VEGFR2 
dimerization and activation.   
Cdc42 and Rac1 are mainly active in the leading edge of a cell, organizing lamellipodia and 
filopodia. RhoA activity is restricted to the trailing edge where stress fiber mediated contraction is 
predominantly important. The size ratios of the signaling proteins and the cell do not reflect reality. 
Signaling mechanisms are described in the text.  
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nucleation points and is thus of high importance in branched networks located in the 
lamellipodium for instance (Volkmann et al. 2001). 
The third important GTPase regulating cellular motility is RhoA. RhoA is activated via 
VEGFR2 signaling in a HSP90-dependent manner (Le Boeuf et al. 2004). Important 
effectors of RhoA are the phosphoinositide-3 kinase (PI3K), as well as the Rho associated 
kinase (ROCK). ROCK itself has many targets which affect actin cytoskeleton 
reorganization e.g. the focal adhesion kinase (FAK). FAK is organized in focal adhesion 
clusters, where it plays a pivotal role in adhesion and cellular motility (Higuchi et al. 2013). 
Moreover, ROCK is a potent mediator of cellular contractility by phosphorylating the 
regulatory myosin light chain directly and additionally phosphorylating and thereby 
deactivating the myosin light chain phosphatase (Riento and Ridley 2003) [Fig. 2.3]. 
Additionally, direct activation of mDIA1 and indirect ROCK-mediated inhibition of Cofilin 
via LIM-kinase regulates actin polymerization of stress fibers (Lamalice et al. 2007) 
[Fig.2.2]. In general, RhoA can be seen as an important regulator of stress fiber 
maintenance. 
It is mentionable, that Rac1 and Cdc42 are predominantly active in the leading edge of a 
cell (near lamellipodia and filopodia), while RhoA activity is more restricted to the trailing 
edge (where stress fiber formation and thus contraction predominantly occurs) (Parsons, 
Horwitz, and Schwartz 2010) [Fig. 2.2]. These spatially restricted activities reflect the 
different tasks of Rho GTPases in cellular migration and actin reorganization. For example 
it has been shown that Rac1 suppresses RhoA in the leading edge by activating its 
GTPase activating protein p190RhoGAP (Nimnual et al. 2003). In contrast to this, RhoA 
suppresses Rac1 activity near the trailing edge by activation of filGAP, a GTPase 
activating protein of Rac1 (Ohta et al. 2006; Burridge and Doughman 2006). 
Beside the previously described GTPases, other essential factors exist to modulate 
endothelial cell migration via VEGFR signaling. Upon phosphorylation and activation of 
VEGFR, the adaptor molecule Shb binds directly to the intracellular domain of the VEGFR 
via a SH2 domain (Holmqvist et al. 2004). This results in recruitment and activation of 
PI3K, leading to local production of PIP3 by phosphorylation of membrane lipids. Signaling 
proteins which harbor a PH (pleckstrin homology) domain can bind to PIP3 and thus are 
recruited to the membrane. A prominent effector of PI3K is AKT/PKB, which is a potent 
mediator of actin remodeling and cellular motility in endothelial cells 
(Morales-Ruiz et al. 2000). Among others, AKT/PKB targets FAK, previously mentioned 
as an important regulator of adhesion. Likewise, the previously mentioned GEFs and 
GAPs often harbor PH domains. Thereby, PI3K signaling also contributes to Rho GTPase 
regulation (Welch et al. 2003).  
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Fig. 2.3 Molecular pathways involved 
in the generation of tension via actin-
myosin contractility.  
MLCK is activated by binding of 
Calmodulin, a Ca2+ binding protein. 
Activated MLCK enhances contractility by 
phosphorylation of the regulatory light 
chain of myosin II. ROCK which is 
activated by RhoA, inhibits the myosin 
light chain phosphatase (MLCP), and 
directly phosphorylates the regulatory 
light chain of myosin II, controlling 
contractility in two different ways. 
2.3.2 Regulation of actin-myosin contractility in endothelial cell migration 
The actin-myosin system in non-muscle cells is an evolutionary highly conserved 
mechanism for the creation of mechanical tension. This is important on a molecular but 
also on a cellular level as contractility is the central regulator of cell shape (Parsons, 
Horwitz, and Schwartz 2010). Contractility is crucial for cellular migration, being 
responsible for stress fiber-mediated trailing edge retraction (Lamalice et al. 2007). Stress 
fibers consist of approximately 10 to 30 actin filaments which are cross-linked by α-actinin 
and organized in an anti-parallel manner (Tojkander et al. 2012). Functionally they are 
linked to focal adhesions either solely on one side (dorsal stress fibers) or on both sides 
(ventral stress fibers) (Tojkander et al. 2012). Stress fibers are found all over the cell 
body, but are concentrated in the central and rear regions of a cell. They provide a 
scaffold for myosin II filaments which generate molecular tension by moving two actin 
filaments together and thus shorten the stress fibers (Murrell et al. 2015). Myosin II 
consists out of two heavy chains, two regulatory light chains (RLCs), and two essential 
light chains (ELCs). Myosin is organized in bipolar bundles to interact with filamentous 
actin (f-actin) via the so called head domains of the heavy chains (Vicente-Manzanares et 
al. 2009). Upon ATP hydrolysis, the head domain undergoes a conformational change 
and the actin filaments of the stress fibers are pulled towards each other in a “power 
stroke” mechanism (Málnási-Csizmadia et al. 2010). The regulation of myosin motor 
activity is mediated by phosphorylation and de-phosphorylation of Thr18 and Ser19 at the 
RLCs (Shen et al. 2010). An increased phosphorylation results in an increased myosin II 
motor activity. In endothelial cells this is achieved by two main proteins, which are 
displayed in Figure 2.3. One of these proteins is the previously described Rho associated 
kinase (ROCK), which directly phosphorylates the RLC, but also prevents de-
phosphorylation of the RLC by inhibiting the myosin light chain phosphatase (MLCP). The 
second protein is the myosin light chain kinase (MLCK) which is activated by the calcium 
binding protein Calmodulin and also directly phosphorylates the RLC of myosin II (Shen et 
al. 2010). 
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2.4 Tip cell formation 
Regulation of the factors described in section 2.2 is tightly controlled to allow a directed 
migration of a cell collective towards an VEGF-A gradient during sprouting angiogenesis 
(Gerhardt et al. 2003). In order to coordinate the movements within a new sprout, only 
specialized tip cells express high levels of VEGFR2, leading the cellular collective into a 
hypoxic area (Gerhardt et al. 2003).  
Tip cell formation is a fundamental process for sprouting angiogenesis and depends 
mainly on the differentiation of specialized cells, leading a new sprout towards a specific 
angiogenic stimulus consisting of VEGF and other cytokines. The selection of tip cells 
(and stalk cells) is the result of a cellular competition depending on DLL4-Notch, an 
evolutionary highly conserved cell-cell contact-dependent signaling mechanism 
(Artavanis-Tsakonas et al. 1999) [Fig. 2.4]. In general, a tip cell is defined by its specific 
set of receptors (Blanco and Gerhardt 2013; Jakobsson et al. 2010), expression or 
repression of characteristic genes (Siemerink et al. 2012; del Toro et al. 2010; Strasser et 
al. 2010), a high number of dynamic filopodia (Gerhardt et al. 2003), its front position in 
the sprout, and the low proliferative activity (Gerhardt et al. 2003). In contrast to this, stalk 
cells are highly proliferative and establish adherent and tight junctions for lumen formation 
and to provide vascular stability to the new sprout (Blanco and Gerhardt 2013). There are 
various factors involved in the process of tip and stalk cell selection, but for reasons of 
simplicity only the interplay of VEGFRs and Notch signaling will be described in more 
detail. 
Initially in the sprouting process, a cell from a (re)activated preexisting vessel loses 
attachment to the neighboring cells, degrades the basement membrane, and starts to 
migrate along the VEGF gradient (Blanco and Gerhardt 2013). The initial selection of a 
cell to become a tip cell is presumably random and mainly dependent on the VEGFR2 
expression of the cell at the time point of local VEGF level increase (Jakobsson et al. 
2010). While tip cells display a high DLL4 and VEGFR2 (high kinase activity) expression 
level but low levels of VEGFR1 (very low kinase activity), stalk cells display low levels of 
VEGFR2 and DLL4, but high levels of VEGFR1 [Fig. 2.4]. High levels of the membrane 
bound delta-like ligand 4 (DLL4) in tip cells leads to an increased Notch signaling 
activation in neighboring cells resulting in a decrease of DLL4 and VEGFR2 expression, 
but an increase of VEGFR1 expression [Fig. 2.4]. This ensures that only single cells 
obtain the tip cell phenotype, while other cells are laterally suppressed and obtain a 
phenotype characteristic for stalk cells. As tip cells lead the sprout, they usually possess 
less cell-cell contacts compared to stalk cells resulting in a decreased Notch signaling and 
thus additional stabilization of the tip cell phenotype. Moreover, the high VEGFR2 levels in 
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tip cells are responsible for the high number of filopodia which are a characteristic feature 
of tip cells but have been shown to be dispensable for the guidance of new sprouts 
(Phng et al. 2013). In stalk cells, the low VEGFR2 but high VEGFR1 expression levels 
result in a reduced response to VEGF-A as VEGFR1 mainly acts as a decoy receptor, due 
to its low intrinsic kinase activity but very high affinity to VEGF-A (Jakobsson et al. 2010). 
As DLL4 expression is dependent on VEGFR signaling [Fig. 2.4], the low sensibility to 
VEGF ensures low levels of DLL4, hence stabilizes the stalk cell phenotype, as the cell is 
not capable of suppressing neighboring cells via Notch signaling. While tip cells ensure a 
coordinated movement of the cell collective, stalk cells build up the lumen and form the 
novel blood vessel. This whole process is highly dynamic and cells in the tip cell position 
of a new sprout might change frequently during sprout progression 
(Jakobsson et al. 2010). 
 
Fig. 2.4 Tip and stalk cell competition upon a VEGF-A gradient.  
Initially, VEGF-A binds to VEGFR2. VEGFR2 signaling leads to increased expression of the 
membrane bound ligand DLL4 in tip cells, resulting in enhanced Notch signaling in neighboring stalk 
cells. The enhanced Notch signaling in stalk cells results in low VEGFR2 but high VEGFR1 
expression, making the cell insensitive to VEGF stimulation, which in turn stabilizes the stalk cell 
phenotype. The low levels of DLL4 in the stalk cells results in low Notch signaling in the tip cells, 
stabilizing the tip cell phenotype by up-regulation of DLL4 and VEGFR2 and down-regulation of 
VEGFR1. Figure adapted and modified from Blanco and Gerhard, 2013. 
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2.5 Adhesion and contractility as regulatory mechanisms of plasma 
membrane blebbing  
In contrast to the “classical” cell protrusions (e.g. filopodia and lamellipodia), which are 
regulated by the Rho GTPase protein family (described in section 2.2), membrane blebs 
become more and more important in cell biology, being crucial for cellular migration of 
leukocytes (Lämmermann et al. 2008), or as an alternative migration mode of cancer cells 
(Wolf et al. 2003). Importantly, membrane blebs, playing a role in migration processes, 
have to be distinguished from blebs observed in apoptotic processes (Coleman et 
al. 2001). In this section, only the formation of membrane blebs in the context of migration 
and spreading will be described in more detail, including many mechanistic similarities to 
apoptotic blebs. 
Plasma membrane blebs expand as a result of intracellular hydrostatic pressure (Charras 
et al. 2005). This is in contrast to other cellular protrusions like lamellipodia, where actin 
polymerization is the driving force (Charras and Paluch 2008). Retraction of the 
membrane blebs occurs through polymerization of actin at the bleb cortex and subsequent 
retraction of the bleb towards the cell body happens in an actin-myosin contractile-
dependent manner (Charras et al. 2006). To date, many molecular players associated 
with the actin cytoskeleton have been identified to be either essential or not important for 
bleb formation (reviewed in Fackler and Grosse 2008). One major regulator of membrane 
blebbing is the previously described Rho-ROCK signaling pathway due to its potential to 
provide cellular contractility. Beside the necessity of contractility in bleb retraction as 
mentioned before, contractility has been shown to be a critical inducer of membrane blebs 
due to induction of local ruptures in the cell cortex (Paluch et al. 2006; Ruprecht et al. 
2015). In contrast to the knowledge about intracellular mechanism, extracellular cues 
which provoke bleb formation are rather unknown. To date, the best analyzed extracellular 
cause of plasma membrane bleb formation is the change, loss, or reduction of adhesion, 
for example during cell spreading. Moreover, it has been shown that leukocytes migrate in 
an integrin-independent and bleb-based manner (Lämmermann et al. 2008). Another 
study showed that softness of the substrate is critical for bleb formation of breast cancer 
cells (Kitzing et al. 2007). To date, plasma membrane blebbing of endothelial cell biology 
has been exclusively described in the context of cell spreading (Norman et al. 2011), 
which can be likewise seen as a temporal low adhesive state. In the first part of this study, 
it is demonstrated that plasma membrane blebbing is inducible in endothelial cells through 
spatial confinement and enhancement of contractility in a defined setup. Additionally it is 
shown, that blebbing plays a role in 3D migration of endothelial cells as a dynamic and 
important reaction to low adhesive environments. 
2. Introduction 
11 
2.6 Current models to investigate angiogenesis 
The establishment of new models for the investigation of angiogenesis is of great 
importance and has been addressed in this study. A brief overview of existing models and 
assays will be given in this section. All models described can be divided into four 
categories – in vitro models (e.g. tube formation assay), ex vivo models (e.g. aortic ring 
assay), in vivo models (e.g. CAM assay) and in silico modeling. As all of them are specific 
to certain aspects of angiogenesis, all of them possess their advantages and 
disadvantages. Usually, a combination of assays is applied in laboratory routine to fully 
evaluate the effects of e.g. pharmacological compounds and to create a good scientific 
base for the in vivo translation.  
 
2.6.1 In vitro assays 
Like for other cell types, behavior of ECs upon specific stimuli can be tested using 
standard in vitro cell biological methods including assays for proliferation 
(e.g. cell-counting after a specific time; MTT assays) and migration (e.g. boyden chamber 
assay, scratch assay). As both differentiation and migration play a pivotal role in sprouting 
angiogenesis, these assays usually provide a good first overview on endothelial cell 
behavior as they are technically easy to handle and usable for large screening 
experiments.  
Beside the standard cell assays, the most common in vitro assay for investigation of 
angiogenesis is the “tube formation assay”. Here, cells are cultured under conditions 
where they built a capillary-like network structure. This morphogenetic process of network 
formation is often used as a read-out for the pro- or anti-angiogenic effects of compounds 
in laboratory routine. The tubule-like structures can be observed in short time experiments 
on a layer of a gel matrix after three to six hours (Arnaoutova and Kleinman 2010). Also 
3D approaches have been experimentally addressed, where tubule-like structures are 
formed between two layers of gel matrices (Gagnon et al. 2002). These experiments 
better mimic the in vivo situation but are usually technically challenging and difficult to 
analyze.  
Although the tube formation assay is the only well established system to test for the 
morphogenetic potential of ECs in an in vitro approach to date, results obtained from 
these experiments have to be interpreted with caution. The main reason for this is that the 
process is not endothelial-specific as other cell types were shown to build up networks 
under certain conditions - cells which do not form networks in vivo (Donovan et al. 2001). 
However, results from our laboratory proved, that conclusions drawn from tube formation 
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assays are in general in line with results obtained from migration assays, implying that 
overall migratory potential is more important than the ability of morphogenesis. In the last 
years multiple microfluidic setups have been established to test endothelial cells under 
in vivo-like conditions (e.g. under shear stress) (Shao et al. 2009; Abaci et al. 2014). So 
far, these approaches have not emerged to be accessible to a broad range of users, but 
harbor a huge potential for future EC-based research. 
 
2.6.2 Ex vivo assays 
Ex vivo assays are described as methods which allow the withdrawal and cultivation of 
organs or tissues from mice (or other animals) in order to elucidate the complex process 
of angiogenesis in an in vivo-like situation. One of the most common ex vivo assays is the 
“aortic ring assay”. Herby, small, approximately 1 mm wide rings of a mouse (or rat) aorta 
are embedded into a three dimensional matrix like matrigel or type I collagen 
(Baker et al. 2012). After five to nine days, micro-vessels sprout from the aortic ring into 
the gel and can be quantified regarding their number and length. Likewise, cell coverage 
of the micro-vessels with pericytes can be quantified using antibody immuno-stainings for 
respective marker proteins like NG2 (Ozerdem et al. 2001). Moreover, micro-vessel 
structures and lumen formation are addressable using the 3D reconstruction capabilities 
of confocal microscopy. Beside the testing of pharmacological compounds on their 
antiangiogenic effects, cell treatment via siRNA transfections are feasible using this 
system (Baker et al. 2012). Moreover, aortas from transgenic mice are adaptable to this 
system, in order to compare their angiogenic potential upon knockout conditions (Baker et 
al. 2012). The main advantage of this assay is that ECs are in a natural-like environment, 
being surrounded by a three-dimensional matrix embedding other cells which are known 
to play a role in angiogenesis (e.g. pericytes). However, the main disadvantage of the 
system is the huge variability, especially between different animals, implicating the 
necessity of accurate quantification. Moreover, always non-human material is used which 
makes the translation to clinical trials even more challenging. 
 
2.6.3 In vivo assays 
In vivo assays for angiogenesis are numerous and are performed in various model 
animals like zebrafish, mouse, or rat. The most common assays are the chick 
chorioallantoic membrane (CAM) assay, the dorsal skinfold chamber assay, and various 
tumor models. Here, only the CAM assay and the tumor models will be described in more 
detail.  
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The CAM is a highly vascularized membrane which serves as a gas exchange barrier and 
is accessible outside the chick embryo (Staton et al. 2009). Sprouting angiogenesis in the 
CAM is observed between day five and day twelve after starting the incubation of the 
fertilized egg. A small window in the egg shell allows manipulation of the CAM inside the 
egg shell. Alternatively, the embryo is artificially cultured in a petri dish without the egg 
shell. This system allows the testing of potentially antiangiogenic substances or even the 
cultivation of xenografts tumors or human cancer cells (Staton et al. 2009). The 
advantages of the CAM assay are low costs and simplicity, making the system suitable for 
high-throughput screenings. The disadvantages are the non-mammalian origin, the 
differentiation of new vessels from preexisting ones and the occurrence of both sprouting 
and intussusceptive angiogenesis.  
Tumor models in mice are widely used in laboratory routine as they provide the only 
possibility to investigate angiogenesis in vivo in a mammalian model system. The most 
common method to achieve this is the subcutaneous injection of tumor cells into the mice. 
Upon formation of a solid tumor, treatment with the substance of interest can be 
investigated. In order to estimate the antiangiogenic potential of the substance of interest, 
the tumor size is measured at regularly time periods, vascularization of the tumor tissue is 
estimated and the tumor volume is quantified at the end of the study.  
 
2.6.4 In silico modeling 
In silico modeling of angiogenic processes is efficient as angiogenesis relies on pattern 
formation based on cell-cell contact-dependent regulation of receptor expression as well 
as on gradients of specific stimuli as described in section 2.3. Thus, the computation of 
processes like tip cell formation based on existing experimental data is feasible and useful 
(Bentley et al. 2009). As structured surfaces provide a highly controllable environment, 
experimental data obtained with these novel approaches likely provide a stable and 
reproducible experimental basis for computational analyses of complex processes. The 
second part of this thesis investigates structured surfaces as a tool to model tip cell 
formation. 
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2.7 Structured surfaces in cell biology 
2.7.1 Importance of structured surfaces in cell biology  
Structured surfaces and other artificial systems gained more and more importance in the 
last years, as cell biology in the traditional 2D cell culture is artificial. Moreover 2D cell 
culture allows for a very undifferentiated and limited analysis of cellular behavior. Cells in 
a flat cell culture dish (usually consisting of rigid polystyrene) face a uniform, infinite, and 
stiff environment (Théry 2010) [Fig. 2.5]. In contrast to this, cells in situ face very specific 
microenvironments with spatial confinement, restricted space for spreading, or specific 
numbers of neighboring cells [Fig. 2.5]. With structured surfaces, it is possible to 
reconstitute the various micro-environments on a flat surface, and to analyze the cellular 
response in high quality and quantity.  
In general, micro-patterns allow for the manipulation of many cellular processes. The most 
common reactions of cells cultured in confined environments or on micro-structures are 
the massive changes in actin cytoskeleton architecture (Théry et al. 2006). Cells cultured 
on T- or V-shape patterns form pronounced stress fibers in order to over-span the 
non-adhesive regions. These fibers are contractility dependent and diminish using the 
Fig. 2.5 Microstructures can be used to reconstitute cellular micro-environments.  
Cells face a stiff, uniform, infinite, and static environment in an in vitro environment (2D cell 
culture). This is in contrast to their in situ situation where they face very specific 
micro-environments. Micro-patterning can be used to reconstitute the physiological 
micro-environments on a flat surface and to analyze cellular behavior in a high quantity and quality. 
Figure adapted and modified from Théry 2010. 
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ROCK inhibitor Y27632 (Théry et al. 2006). Furthermore, adhesion sites are only formed 
at the sites of highest tensional stress (Théry et al. 2006). Micrometer-sized ECM-protein 
dots helped to elucidate the maximal distance between adhesion sites, which is between 
58-73 nm for different cell types, respectively (Arnold et al. 2004). Moreover, 
micro-patterns have been used to study and modify intracellular polarity. With 
asymmetrical patterns, it has been shown that endocytosis is dependent on extracellular 
cues (Grossier et al. 2014), and that directed cell migration is inducible by using tear drop 
shaped patterns (Jiang et al. 2005). Moreover, lamellipodium formation is controllable by 
asymmetric shaped micro-patterns (James et al. 2008). Other striking findings were the 
dependencies of centrosome and Golgi orientation in confined environments. Both cellular 
structures are taken as polarity markers in cell biology as they usually form an axis in the 
direction of migration (together with the nucleus). However, both orientation of 
centrosomes and Golgi apparatus have been shown to change under confined 
environments (Pouthas et al. 2008; Doyle et al. 2009, this study). Additionally, cellular 
differentiation is influenced by micro-patterning, as it has been shown that shape and 
contractile status determine the cell fate (Kilian et al. 2010). 
Migration in combination with micro-patterning has been a central research focus, as 
micro-patterns are used to preset guidance cues in order to facilitate automated analysis 
of migration parameters (Maiuri et al. 2012; Maiuri et al. 2015) or to mimic 3D migration of 
fibroblasts (Doyle et al. 2009). In a very sophisticated study, Maiuri and coworkers 
demonstrated that speed and persistence of cells are exponentially correlated. Further it 
was shown that actin retrograde flow, the actin flow from the lamellipodium towards the 
cell center (Gardel et al. 2008) maintains migration persistence through a positive 
feedback loop mechanism (Maiuri et al. 2015). Moreover, thin protein adhesion cues can 
potentially be used as a model system to mimic 3D migration as protein tracks induces a 
fast and uniaxial migration behavior (Doyle et al. 2009; Doyle et al. 2012). 
The previously described examples demonstrate the potential of micro-patterning 
approaches in cell biology. Most of these studies were carried out on plastic, glass, or 
polydimethylsiloxane (PDMS) surfaces as they are suitable for easy-to-handle 
micro-patterning techniques like micro-contact printing. However, as the field of 
micro-patterns progresses, new techniques are introduced, which can be used to 
manipulate cell behavior dynamically e.g. with the help of photo-switchable patterns 
(Rolli et al. 2012). Likewise, the possibility of patterning soft and sticky substrates is a 
great tool to decipher cellular reactions to spatial confinements and specific geometries in 
the future (Yu et al. 2012). 
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2.7.2 Structured surfaces in endothelial cell biology 
As this study focuses on EC reactions to micro-patterns, some common approaches using 
micro-patterns with their background in angiogenesis are introduced in this section. 
Micro-patterns were used to create linear tracks, mimicking cell shape of ECs under fluid 
shear stress (Vartanian et al. 2010). Likewise, mechanical properties of endothelial cells 
are influenced by micro-patterns as elongated cells possessed a higher stiffness 
compared to control cells (Kidoaki and Matsuda 2007). Additionally, nucleus deformation 
of ECs has been in the focus of researchers. Versaevel and coworkers demonstrated a 
correlation between cell elongation and nucleus deformation resulting in an altered 
chromatin condensation and proliferation rate of ECs (Versaevel et al. 2012). 
A question often addressed is whether tube formation on micro-patterned surfaces is 
possible and if so, if it is influenced by the dimension of the substratum. Lines of different 
widths have been used to produce cell tubes with different diameters. After a distinct time 
of cultivation a lumen was observed (Dike et al. 1999; Lei et al. 2012), suggesting that 
spatial restriction is a critical parameter for tube formation. Similarly, indirect patterning 
was performed by cultivation of ECs on a patterned glass slide and subsequent transfer 
onto a Matrigel layer. Herby, cells formed tubes in the dimensions of the preset patterns 
(Okochi et al. 2009). In the future, this approach will provide information about geometrical 
constraints of tube formation in a highly controlled setting.  
Migration behavior of ECs on micro-patterns has been rudimentarily elucidated to date. It 
has been shown that ECs migrate faster on 15 µm wide tracks compared to 30 and 60 µm 
wide tracks (Li et al. 2001). This is in contrast to another study where researchers showed 
a decreasing velocity with decreasing tracks width (Lei et al. 2012). Another study was 
performed with implemented medium flow into the experimental setup. ECs migrated 
faster when the flow was parallel to the direction of migration. When the flow was 
perpendicular, the cells migrated less efficient (Lin and Helmke 2009). However, no 
comprehensive analysis of migration behavior of single ECs on migration tracks, was 
performed so far. The first part of this study focuses on EC migration on micro-patterns, 
elucidating differences to existing studies and to other cell types.  
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2.8 Aim of the study 
Several models for angiogenesis are used in laboratory routine to date. However, most of 
the common models are technically challenging, difficult to interpret and quantify, and thus 
poorly predictive for the in vivo situation. Moreover, no reliable in vitro assays exist, being 
accessible to a broad range of laboratories. Angiogenesis is a process based on the 
formation of patterns, networks, and shapes. These features make angiogenesis suitable 
to be addressed with structured surfaces, like specific patterns can be preset in order to 
study morphogenetic processes and migration under spatial restriction.  
To date, no comprehensive cellular characterization of ECs migrating on micro-patterns 
has been performed. The first part of this work focuses on a cell biological 
characterization of ECs on micro-tracks, following the intention to mimic 3D migration by 
using very thin protein guidance cues. As 2D cell culture and migration is very artificial, 
this migration model helps to elucidate migration behavior of ECs in a fibrillary 3D 
environment and provides a technically easy to handle and easy to analyze setup for large 
scale screening experiments.  
Tip cell formation is a highly complex process which is exclusively investigated with 
complex animal models and assays to date. In the second part of this thesis a model for 
artificial tip cell formation on a flat surface is introduced. This model serves to elucidate 
cell-cell contact-dependent processes in a highly controllable and easy to handle setup. 
The aim of this study was the creation and characterization of models based on structured 
surfaces to predict endothelial cell behavior in a highly controlled manner. These models 
are expected to lead the way to complex artificial in vitro systems, which have a higher 
predictive value than the current model systems.  
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Fig. 3.1 Characterization of HUVECs migrating under confinement.   
(A) Representative HUVEC migrating on a DyLight488-labeled fibronectin, 3 µm wide track. 
(B) Comparison of HUVECs migrating on tracks of 3, 10, 20, and 30 µm width. Cells were fixated 
with 4 % pFA, 20 hours after seeding and stained for f-actin and nuclei. (C) Magnification of areas 
marked in (B) of cell migrating on a 30 µm wide track (*) and on a 3 µm wide track (**). 
(D) Railroadfibers of HUVEC migrating on a 3 µm wide track. Cell was stained for f-actin. 
(E) HUVECs on 3 and 30 µm wide tracks stained for nuclei (blue), beta1-integrin (green), and 
f-actin (red). (F) Magnification of areas marked in (E) of HUVEC on 30 µm wide track (***) and 
3 µm wide track (****). White arrowheads mark focal adhesions at the leading edge and at the 
lamellum. Bars equal 10 µm. 
 
 
3. Results 
3.1 Micro-tracks as a tool to study endothelial cell migration 
3.1.1 HUVECs on narrow tracks display less stress fibers and focal adhesions but 
pronounced cortical actin 
The aim of this thesis was to mimic endothelial 3D migration with artificial guidance cues 
[Fig. 3.1A]. As a first step, the behavior of HUVECs migrating on tracks of different widths 
was characterized in order to study overall cellular behavior and to adjust conditions for 
further experiments. The lamellipodal formation was stepwise reduced with decreasing 
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track width as expected [Fig. 1B]. Furthermore, cells migrating on 30, 20, and 10 µm wide 
tracks showed a high amount of stress fibers being distributed over the whole cell body 
[Fig. 3.1B, 3.1C]. In contrast, cells seeded on 3 µm wide tracks exhibited pronounced 
bundles of cortical actin and characteristic “railroad fibers”, bordering the micro-structures 
[Fig. 3.1D]. Additionally, cells on broader tracks (> 3 µm) displayed a high amount of 
lateral lamellipodia while cells on 3 µm wide tracks possessed a very small 
pseudo-lamellipodium at the leading edge and no or only few lateral lamellipodia, 
indicated by f-actin (fibrillary actin) staining [Fig. 3.1B, 3.1C]. As a reduced amount of 
stress fibers was observed on 3 µm wide tracks, cells were stained for focal adhesion 
complexes. For this purpose an antibody against β1-integrin was used. β1-integrin is 
responsible for fibronectin binding in complex with α5-integrin (Yang et al. 1993). 
Confirming our expectations, a reduced amount of focal or nascent adhesions was 
observed on 3 µm wide tracks compared to 30 µm wide tracks [Fig. 3.1E, 3.1F].  
 
3.1.2 Golgi and centrosome localization of HUVECs is regulated independently in 
confined environments 
As Doyle and colleagues showed a different centrosome localization for 2D migrating 
fibroblasts and cells migrating under confinement (Doyle et al. 2009), this was 
investigated for ECs. Moreover, Golgi complex orientation in cells under confinement was 
examined as it was done with Bsc1 cells before (Pouthas et al. 2008). To ensure better 
comparability, cells were seeded on both 3 µm (1D) and 30 µm wide tracks. On the wider 
tracks cells generally had a broad leading edge with a defined migration direction, but a 
morphology similar to cells in 2D environments [Fig. 3.2]. On 30 µm wide tracks, the Golgi 
was located laterally to the nucleus [Fig. 3.2A]. On narrow 3 µm wide tracks the Golgi 
complex was predominantly found laterally to the nucleus [Fig. 3.2B]. Only occasionally, 
the Golgi was located behind the nucleus, near the trailing edge. In contrast to this, 
centrosome orientation changed upon confinement. On 30 µm wide tracks, the 
centrosomes were predominantly located laterally to the nucleus [Fig. 3.2C] even though 
the values displayed a higher variance compared to the data describing Golgi orientation. 
On narrow 3 µm wide tracks, the centrosomes were mainly located behind the nucleus 
near the trailing edge. During relaxation of the cell on 3 µm wide tracks (e.g. during a 
directional reorientation), the cellular polarity was lost as described in section 3.1.5 in 
more detail. On 3 µm wide tracks this resulted in a switch of the centrosome from a 
posterior to a lateral position in relation to the nucleus (data not shown). 
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Fig. 3.2 Position of the 
centrosome and Golgi in 
confined environments. 
Position of the Golgi 
complex in relation to the 
nucleus center of HUVECs 
on (A) 30 µm wide tracks 
and (B) on 3 µm wide 
tracks. The position of the 
centrosomes in relation to 
the nucleus is shown for 
HUVECs migrating on 
(C) 30 µm wide tracks and 
(D) on 3 µm wide tracks. 
White arrowhead mark 
centrosome. 45 cells were 
analyzed per setting. 
Images for quantification 
obtained from three 
individual experiments. Bars 
equal 10 µm. 
 
 
 
3.1.3 HUVECs on 3 µm wide migration tracks display a compressed nucleus shape 
The nucleus is considered to play a pivotal role in cell migration in confined spaces as it is 
much stiffer compared to the residual components of the cell (Dahl et al. 2008). 
Consequently, the shape of the nucleus under confinement was characterized [Fig. 3.3]. 
For that purpose the shape factor of various nuclei was determined, by calculating the 
quotient of two diameters (d1 and d2) perpendicular to each other. A perfect circle 
possesses a shape factor of 1. Nuclei of HUVECs seeded on 3 µm wide tracks were very 
significantly elongated (shape factor close to 0) compared to nuclei of cells on 30 µm wide 
tracks [Fig. 3.3A]. Cells seeded on fibronectin 2D plastic surfaces showed a significantly 
rounded morphology compared to cells on 3 µm wide tracks [Fig. 3.3A]. The differences 
in shape of nuclei of cells on 30 µm wide tracks compared to cells in 2D were mild but 
robust. Additionally, an alteration of chromatin condensation in nuclei of cells on 3 µm 
wide tracks was observed. The characteristic “railroad fibers” carved into the nucleus, 
caused a local increase in chromatin condensation, visualized by Hoechst staining 
[Fig. 3.3B]. This effect has been exclusively observed in cells on 3 µm wide tracks. On 
broader tracks condensed chromatin was evenly distributed. Importantly, solely polarized 
cells which have been classified as migrating at the time point of fixation were analyzed 
[Fig. 3.3]. Conceivably, nuclear shape might additionally change on narrow 3 µm wide 
tracks, during relaxation of the cell e.g. being induced by a directional reorientation.  
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3.1.4 HUVECs migrate less efficient in 1D environments 
As reduced lateral spreading is thought to favor a fast and directed fibroblast migration 
(Doyle et al. 2009), migration parameters of HUVECs migrating on tracks with different 
widths were analyzed. Surprisingly, cells migrating on broader tracks (20 µm and 30 µm) 
showed a significantly higher mean velocity compared to cells migrating on 3 µm wide 
tracks [Fig. 3.4A], even though cells on broader tracks displayed a high number of lateral 
lamellipodia as visualized by cortactin immuno-staining [Fig. 3.4B]. Additionally, 
directionality calculated from the quotient of total cell displacement and total trajectory 
length was assessed. Cells migrating on thin 3 µm and 10 µm wide tracks changed their 
direction more frequently during the migration process in comparison to cells on wider 
tracks [Fig. 3.4C]. As the narrow migration tracks mimic an environment with limited 
adhesion, the spreading area of cells on different track widths was quantified. A linear 
reduction of adhesion area was observed with decreasing track width [Fig. 3.4D]. 
Kymographic analysis of cells migrating on 3 µm wide tracks revealed that cells displayed 
a very high dynamic fluctuation in the leading and trailing edge [Fig. 3.4E]. In contrast 
cells on 30 µm wide tracks protruded and retracted very evenly over the observation time 
[Fig. 3.4F]. As both directionality and mean velocity decreased on thinner tracks, the 
contribution of the low directionality to the low mean velocity was assessed. This is 
necessary, as frequent cell stops during the migration process result in a strongly reduced 
mean velocity, even though the cells might not migrate slower between two reorientation 
phases. For this purpose a change point analysis (bimodal analysis) was performed, 
dissecting cell trajectories in migration phases (=run) and orientation phases (=rest) 
[Fig. 3.4G] (performed in cooperation with Prof. Joachim Rädler, LMU Munich). This 
allowed the calculation of run velocities comprising only the migration phases in between 
two orientation phases. In addition, persistence times were calculated by survival function 
analyses. In addition to changes in mean velocity of cells migrating on different track 
width, a reduction of run velocities on narrow migration tracks was observed [Fig. 3.4H]. 
Fig. 3.3 Impact of confinement on the 
nucleus shape.  
(A) Nucleus shape factor of HUVECs 
migrating on 3 µm wide tracks, 30 µm 
wide tracks, and on a fibronectin coated 
surface (2D). n = 3; Mean ± SEM; t-test 
p***< 0.001. (B) Railroad-fibers induce 
locally enhanced condensation of 
chromatin in the nucleus (arrowheads). 
Cells were stained with 
rhodamine-phalloidin and Hoechst 
33342 for visualization of f-actin and 
nuclei, respectively. Bar equals 10 µm. 
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Fig. 3.4 Characterization of HUVECs migrating under confinement.  
(A) Mean velocity of HUVECs migrating on tracks of different widths and 2D surfaces. (B) Confocal 
images of cells on tracks of 3 µm and 30 µm width stained for f-actin, nuclei, and cortactin. Bars 
equal 10 µm. (C) Directionality analysis of HUVECs migrating on different track widths. 
(D) Spreading areas of HUVECs on different track widths. (E) Representative HUVEC migrating on 
a 3 µm track at different timepoints with corresponding kymograph. Framerate: 2/min. Nucleus is 
marked in blue. (F) Representative HUVEC migrating on a 30 µm wide track at different time points 
with corresponding kymograph. Framerate: 2/min. LE = Leading edge; TE = Trailing edge; 
N = Nucleus. Nucleus is marked in blue. (G) Example of track analysed with the bimodal change 
point analysis. Green = run phases contributing to run velocity. Red = Rest phases were cells 
change direction and don’t move. (H) Run velocity analysis of HUVEC migrating on different track 
widths. (I) Persistence time analysis calculated via survival function analysis. n = 3; Mean ± SEM. t-
test p**<0.01; p***<0.001; n.s. = not significant.  
 
 
Moreover, cells migrating on narrow tracks displayed a very low persistence time 
compared to cells migrating on wider tracks [Fig. 3.4I].  
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3.1.5 Contractility as a fundamental regulator of motility and cell shape in 1D 
migrating cells – HUVECs in 1D switch between two morphological modes 
The frequent changes of migration direction on 3 µm wide tracks were often accompanied 
by pronounced membrane blebbing. In contrast cells in the migration mode displayed a 
lamellipodium as cellular protrusion and only few or no blebs [Fig. 3.5A; compare 
Movie S1 and Movie S2; Movies are found on the compact disc attached to this thesis; 
Movie descriptions are in the appendix]. In order to visualize cytoskeletal dynamics of the 
differential cellular protrusions, cells were transfected with cortactin-GFP and LifeAct-RFP 
and seeded on 3 µm wide tracks. Cells in the migration phase showed strong membrane 
ruffling at the leading edge [Movie S3] while cells in the orientation mode displayed a 
common bleb expansion and retraction cycle [Movie S4]. As membrane blebbing is a 
result of high cortical contractility, contractile areas of the cytoskeleton were investigated. 
Therefore, cells on 3 µm wide tracks were immuno-stained with an antibody targeting the 
phosphorylated and thus active form of the myosin light chain (ppMLC). Cells in the 
orientation mode displayed a very high cortical contractility over the whole cell body. In 
contrast, cells in the migration mode displayed contractility exclusively at the trailing edge 
[Fig. 3.5B]. The high contractility in the orientation mode was accompanied with reduction 
of cell length as a strong correlation of cell length and the total number of membrane 
blebs was observed [Fig. 3.5C]. As the two modes displayed two different contractile 
states, cells were treated with Blebbistatin, a myosin II inhibitor (Kovács et al. 2004), and 
Calyculin A, a compound which enhances contractility (Ishihara et al. 1989). 
Subsequently, migration trajectories and cellular morphologies were analyzed and 
compared. Surprisingly, mean velocity of 1D migrating cells was significantly reduced after 
both Blebbistatin (by 34 %) and Calyculin A treatment (by 17 %) [Fig. 3.5D]. In line with 
our expectations, Calyculin A treated cells showed a reduced cell length [Fig. 3.5E] and 
enhanced cell bleb formation in comparison to control cells [Fig. 3.5F]. In contrast, 
Blebbistatin treated cells displayed a strongly elongated and polarized morphology, 
harboring long cellular protrusions and a relatively small cell body compared to control 
cells [Fig. 3.5E, 3.5F]. As a connection between membrane blebbing and cellular 
reorientation was observed, cell trajectories were analyzed with regard to directionality in 
more detail. In the analysis, persistence of Blebbistatin treated cells was significantly 
increased (by 78 %), whereas Calyculin A treated cells tended to reorient more often 
reflected by a non-significant directness of cell migration [Fig. 3.5G]. However, a high 
contractile and thus un-persistent cell population might have been lost by treatment with 
Calyculin A. One indication for this is the observation that contraction was accompanied 
with decreasing spreading area after Calyculin A treatment [Fig. 3.5E]. 
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3.1.6 HUVECs migrating on 2D surfaces move faster but less persistent upon 
contractility inhibition 
To further compare aspects of the newly established 1D cell migration system to a 
conventional 2D system, cells migrating on fibronectin-coated plastic surfaces were 
treated with Blebbistatin or Calyculin A. Subsequently migration trajectories and cellular 
morphologies were analyzed and compared. The identification of appropriate compound 
concentrations was achieved by performing scratch assay analyses. Blebbistatin did not 
interfere with cell migration, independently of the applied concentration [Fig. 3.6A]. In 
contrast, Calyculin A inhibited cell migration in concentrations of 0.2 to 0.5 nM [Fig. 3.6B]. 
To further investigate cellular reaction of HUVECs in 2D environments to Blebbistatin and 
Calyculin A treatment, experiments were performed on a single cell level. Remarkably, 
HUVECs treated with Blebbistatin showed a very strong morphological reaction, resulting 
Fig. 3.5 Role of contractility for HUVECs migrating on 1D microtracks.  
(A) HUVEC migrating on a 3 µm wide track display different morphologies: a lamellipodium based 
migration mode (*) and a bleb-based reorientation mode (**). (B) HUVEC in migration and 
reorientation mode immuno-stained for phosphorylated form of MLC (ppMLC), nuclei, and f-actin. 
(C) Pearson correlation of cell length and number of blebs (r = - 0.5232; p = 5 * 10-10). Red line 
indicates data trend. (D) Mean velocity analysis of HUVECs migrating on 3 µm wide tracks. Cells 
were treated with 10 µM blebbistatin (bleb) or 250 pM Calyculin A (cal A), respectively. (E) 
Spreading area of cells on 3 µm wide tracks treated with 10 µM Blebbistatin or 250 pM Calyculin 
A, respectively (F) Representative images of cells treated with 10 µM Blebbistatin or 250 pM 
Calyculin A, respectively. 20 hours after seeding cells were fixated with 4 % pFA and stained for 
nuclei and f-actin. (G) Directionality analysis of HUVECs migrating on 3 µm wide tracks treated 
with 10 µM Blebbistatin or 250 pM Calyculin A, respectively. n = 3; Mean ± SEM. t-test p*< 0.05; 
p***<0.001; n.s. = not significant. Bars equal 10 µm. 
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Fig. 3.6 Role of contractility for HUVECs migrating in 2D.  
(A) Scratch assay analysis with various concentrations of Blebbistatin (bleb). Representative 
images for cells treated with 10 µM Blebbistatin and corresponding control. Cell covered areas are 
displayed in green. Starv = starvation control. (B) Scratch assay analysis with various 
concentrations of Calyculin A. Representative images for cells treated with 500 pM Calyculin A and 
corresponding control control. Cell covered areas are displayed in green. Starv = starvation control. 
(C) DIC images of HUVEC treated with 10 µM Blebbistatin and respective control cell (D) Mean 
velocity analysis of cells migrating on fibronectin coated 2D surfaces. (E) Directionality analysis of 
HUVECs on 2D surfaces treated with 10 µM Blebbistatin or 250 pM Calyculin A, respectively. 
(F) Trajectories of HUVECs treated with Blebbistatin or Calyculin A. (G) Quantification of spreading 
area upon Blebbistatin treatment and respective controll cells. n =3; Mean ± SEM. t-test p***<0.001. 
Bars equal 10 µm. 
in formation of numerous lateral protrusions and lamellipodia [Movie S5] in comparison to 
control cells [Movie S6; Fig. 3.6C]. In contrast, Calyculin A treated cells displayed a 
circular morphology and formed cell blebs very sporadically (data not shown). Further 
analysis of cells migrating in 2D revealed some striking differences in comparison to cells 
migrating in 1D (see section 3.1.5). In the 2D system ECs were slightly faster after 
Blebbistatin treatment compared to control cells (13 %) while cells treated with Calyculin A 
migrated slower by 48 % [Fig. 3.6D]. Analysis of directionality revealed that both 
Blebbistatin and Calyculin A treated cells migrated less persistently (34 % and 
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51 %, respectively) [Fig. 3.6E]. The corresponding trajectories of these analyses are 
displayed in Fig. 3.6F. As an increased adhesion area was observed after Blebbistatin 
treatment in the 1D system (see section 3.1.5), the adhesion area after treatment was 
investigated for cells in the 2D system. Quantification revealed no significant changes in 
adhesion area after Blebbistatin treatment [Fig. 3.6G].  
 
3.1.7 HUVECs migrating in 1D and 3D share common morphological aspects 
A switch of membrane protrusions was observed for HUVECs migrating on thin 1D 
micro-tracks. This raised the question whether this behavior is reflected in an in vivo like 
system. For this purpose cells were seeded in collagen I gels and their overall cytoskeletal 
architecture was compared to the phenotype of the cells migrating in the 1D system. For 
additional control, HUVECs seeded on planar, fibronectin-coated surfaces were analyzed 
[Fig. 3.7]. As described before, two main morphological phenotypes are distinguishable 
on 3 µm wide tracks [Fig. 3.7A]. On the one hand, elongated cells harboring a small 
lamellipodium at the leading edge were observed. On the other hand, many cells 
displayed a contracted and roundish phenotype, equipped with many cell blebs but no 
clear polarization or lamellipodium. In contrast, cells migrating on planar surfaces 
Fig. 3.7 HUVECs migrating in 1D and 3D share common morphological aspects. 
(A) Comparison of main morphologies of HUVECs migrating in 1D (3 µm wide fibronectin track), 
3D (1 mg/ml Collagen I gel), and 2D (fibronectin coated plastic surface). 20 hours after seeding 
cells were fixated with 4 % pFA and stained with rhodamine-phalloidin and Hoechst 33342. 
(B) Cross section profiles of cells in 1D, 2D, and 3D. Cross sections were made in the area of the 
nucleus as indicated by dashed lines in (A). (C) Shape factor analysis of HUVECs in 2D and 
elongated cells in 1D and 3D. Mean ± SEM. 15 cross section profiles of independent cells were 
analysed in every setting. White arrowheads mark membrane blebs. 
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displayed a unimodal phenotype with a clear lamellipodium-based migration mode 
[Movie S6]. In the 3D fibrillary environment of a collagen I gel both mentioned phenotypes 
of cells migrating in 1D were observed [Fig. 3.7A]. One cell population displayed a 
roundish morphology without a clear cell polarization, equipped with numerous membrane 
blebs. A second cell population showed an elongated phenotype with only few or no cell 
blebs [Fig. 3.7A]. It is notable, that cells in both 1D and 3D settings contained no cytosolic 
stress fibers but very pronounced cortical actin bundles. These extreme forms of cell 
morphology do not reflect reality completely as intermediate cell morphologies which were 
elongated but still had cells blebs were detected in both 1D and 3D settings. Additionally, 
z-cross-section-profiles of cells in all three systems were compared to each other 
[Fig 3.7B]. Cells in the 1D system shared a similar cross-section profile compared to 
elongated cells in the 3D system as indicated by the shape factor analyses [Fig. 3.7C]. 
While cells in 2D displayed a flat and spread out phenotype, cells in both 1D and 3D 
environments shared a rounded cross-section profile. In order to visualize the contact 
area of cells to collagen I gels, collagen I was stained in combination with f-actin [Fig. 3.8]. 
The mean fiber width of the collagen I gel was approximately 400 to 600 nm, being six 
times smaller than the average track width of the described 1D system [Fig. 3.8A-B]. In 
contrast to non-migrating blebbing cells [Fig. 3.8C], clear actin cytoskeleton containing 
Fig. 3.8 Characterization of collagen I gel and its interaction with HUVECs.  
(A) Confocal image of immuno-stained collagen I gel. (B) Fiber width quantification of 
immuno-stained collagen I gels. (C) Confocal image of a blebbing, non-migrating HUVEC stained 
for collagen I, nuclei, and f-actin. (D) Confocal image of a HUVEC in the retraction/elongation 
stained for collagen I, nuclei, and f-actin. (E-F) Migrating cell in collagen gel. White arrowhead mark 
actin protrusions. Bars equal 10 µm. 
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Fig. 3.9 HUVECs migrating in a fibrillary 3D environment show morphological transitions 
comparable to HUVECs migrating in 1D.  
(A) Differential interference contrast images of a cell migrating in a collagen I gel revealing 
switches between bleb (*) and non-bleb (**) based cell morphology. (B) Mean velocity analysis of 
HUVECs migrating in a 1 mg/ml collagen I gel treated with 10 µM Blebbistatin or 500 pM Calyculin 
A, respectively. (C) Representative cell trajectories of cells migrating in a collagen I gel treated with 
Blebbistatin or Calyculin A. (D) HUVECs in collagen I gel stained for phosphorylation of the myosin 
light chain (ppMLC), f-actin, and nuclei. (*) round, bleb-based morphology, (**) elongated migration 
morphology. (E) Directionality analysis of HUVECs after treatment with 10 µM Blebbistatin and 
500 pM Calyculin A, respectively. (F) Cells in collagen I gels treated with 10 µM Blebbistatin or 500 
pM Calyculin A, respectively, and stained for f-actin and nuclei. White arrowheads mark thin 
filamentous protrusions. n = 3. Mean ± SEM. t-test; p***<0.001; Bars equal 10 µm. 
extensions were observed in the elongated morphology of 3D migrating cells. These 
extensions were clearly overlapping with the collagen I staining [Fig. 3.8E-F]. Protrusions 
of intermediate cell morphologies, presumably in the retraction or elongation process, 
were sometimes parallel to a collagen I fiber, too [Fig. 3.8D].  
 
3.1.8 HUVECs migrating in a fibrillary 3D environment show morphological 
transitions comparable to HUVECs migrating in 1D.  
ECs displayed a bimodal behavior on micro-tracks (see section 3.1.5). Next, it was 
questioned whether micro-tracks can be used as a tool to predict the impact of 
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contractility influencing compounds to cell migration in 3D. Here, mean velocity, 
directionality, and morphology were considered. Live cell imaging of cells migrating in 
collagen I gels revealed that switching of the round, bleb-based morphology into the 
elongated morphology occurs highly dynamic [Fig. 3.9A; Movie S7]. To differentiate 
between these two contractile modes, cells in collagen I gels were immuno-stained for 
the phosphorylated and thus active form of the myosin light chain. Round, blebbing cells 
possessed a high cortical contractility while elongated cells showed contractility 
exclusively in the presumable trailing edge [Fig. 3.9D] (images provided by Kerstin Kick). 
In tracking analysis of cells migrating in collagen I gels, a reduced mean velocity with 
both Blebbistatin and Calyculin A treatment was observed (reduced by 47 % and 48 %, 
respectively) [Fig. 3.9B]. The corresponding trajectories are displayed in Fig. 3.9C. 
Analysis of directionality revealed, that Blebbistatin treatment leads to an increased 
directionality while Calyculin A treated cells move less persistent [Fig. 3.9E]. Upon 
Blebbistatin treatment, cells reacted with profound elongation of a single cellular 
protrusion and obtained a very elongated morphology with a few very thin lateral 
protrusions [Fig. 3.9F; Movie S8]. In contrast to this, Calyculin A treated cells failed to 
elongate along collagen fibers and switched more often into the round bleb-based 
morphology [Fig. 3.9F; Movie S9].  
 
3.1.9 Impact of actin cytoskeleton disruption on cell motility in 2D, 1D, and 3D 
The actin cytoskeleton plays a fundamental role in cell migration. Therefore, the impact of 
actin cytoskeleton influencing compounds was investigated in regard to changes in 
migration. Cytochalasin D, a compound known to have a disrupting influence on the actin 
cytoskeleton was applied (Schliwa 1982). Additionally, an inhibitor of Ezrin was used. 
Ezrin is a member of the Ezrin/Radixin/Moesin (ERM) family and an important linker 
between actin and the plasma membrane (Gautreau et al. 1999). In order to adjust 
compound concentrations, scratch assays were performed using various concentrations 
of the two mentioned inhibitors. Cytochalasin D showed an inhibition of cell migration in a 
concentration range of 50 to 500 nM within an observation window of 16 hours 
[Fig. 3.10A]. The Ezrin inhibitor NSC668394 displayed an inhibition of migration in a 
concentration range of 10 to 50 µM within 16 hours, in comparison to the respective 
DMSO control [Fig. 3.10B]. Cytochalasin D treated cells displayed a reduced amount of 
stress fibers, no clear leading edges, and a completely disrupted actin cytoskeleton 
architecture [Fig. 3.10C]. Trajectory analysis in single cell experiments revealed, that the 
mean velocity was decreased after treatment with 100 nM Cytochalasin D [Fig. 3.10D]. 
Also the Ezrin inhibitor NSC668394 reduced the mean velocity at a concentration of 
25 µM in single cell analysis [Fig. 3.10E]. 
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Fig. 3.10 Cytochalasin D and the Ezrin inhibitor NSC668394 reduce motility in 2D.  
Scratch assay analysis with (A) the actin disrupting agent Cytochalasin D and (B) the Ezrin 
inhibitor NSC668394, respectively. Compounds were applied in various concentrations. Values 
were normalized to the starvation (starv) control. Images show representative images with 
cell-covered areas in green. (C) HUVECs were treated with 100 nM Cytochalasin D (cyto D) and 
fixated after 20 hours. Images show representative cells stained for f-actin and nuclei. Mean 
velocity analysis of cells treated with (D) 100 nM Cytochalasin D and (E) 25 µM Ezrin inhibitor 
NSC668394, respectively, with corresponding cell trajectories. n =3. Mean ± SEM. t-test; 
p***<0.001; Bars equal 20 µm. 
Likewise, cells migrating on 3 µm wide tracks reacted to the disruption of the actin 
cytoskeleton very strongly [Fig. 3.11]. Cells treated with 100 nM Cytochalasin D displayed 
a significantly reduced mean velocity [Fig. 3.11A]. However, a stronger effect upon 
inhibition of Ezrin was observed for cells migrating on micro-tracks compared to the 2D 
system [Fig. 3.11B]. In total, cells were slowed down by 79 %. In Fig. 3.11C 
representative images of a Cytochalasin D treated cells and control cells are shown. In 
regard to actin morphology, the pronounced cortical actin and the characteristic railroad 
fibers were disrupted in compound treated cells. 
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Fig. 3.11 Cytochalasin D and the Ezrin inhibitor NSC668394 reduce motility of HUVECs 
migrating in a 1D environment.  
Mean velocity analysis of cells treated with (A) 100 nM Cytochalasin D and (B) 25 µM of the Ezrin 
inhibitor NSC668394, respectively. (C) Confocal images of HUVECs treated with Cytochalasin D 
and corresponding control. Cell were fixated 20 hours after seeing and stained for f-actin and 
nuclei. n = 3. Mean ± SEM. t-test; p***<0.001; Bars equal 10 µm. 
Fig. 3.12 Cytochalasin 
D and the Ezrin 
inhibitor NSC668394 
reduce motility of 
HUVECs migrating in 
a 3D collagen matrix. 
(A) Mean velocity 
analysis of cells treated 
with 100 nM 
Cytochalasin D, with 
corresponding cell 
trajectories. (B) Mean 
velocity analysis of cells 
treated with 25 µM of 
the Ezrin inhibitor 
NSC668394, with 
corresponding cell 
trajectories. Mean ± 
SEM. t-test; p***<0.001. 
In summary, in line with 2D and 1D, migration in 3D was decreased with both 
Cytochalasin D and the Ezrin inhibitor NSC668394. Mean velocity was strongly reduced 
with 100 nM Cytochalasin D [Fig. 3.12A] and 25 µM NSC668394 [Fig. 3.12B]. In 3D, cells 
completely failed to elongate along collagen fibers upon both Cytochalasin D and 
NSC668394 treatment. 
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Fig. 3.13 Nocodazole reduces motility of HUVECs migrating in 2D.  
(A) Scratch assay with the microtubule disrupting agent Nocodazole (noco) applied in various 
concentrations. Values were normalized to starvation (starv) control. Images show representative 
images with cell-covered areas in green. (B) Mean velocity analysis of single HUVECs treated with 
50 nM Nocodazole and corresponding control as well as corresponding cell trajectories 
(C) Representative confocal images of HUVECs treated with Nocodazole and DMSO (ctrl). Cells 
were fixated 20 hours after treatment with glutaraldehyde after a MT washout assay was 
performed. Cells were fixated 20 hours after treatment. White arrowhead marks MT rupture. n =3. 
Mean ± SEM. t-test; p***<0.001. Bars equal 10 µm. 
3.1.10 Nocodazole reduces cell motility in 2D and 3D systems but not in the 1D 
system 
Beside actin filaments, also microtubules (MTs) as a component of the cytoskeleton play 
an important role in cell migration. Thus the importance of MTs in 1D, 2D, and 3D systems 
was tested by using the disrupting agent Nocodazole (Vasquez et al. 1997). In order to 
adjust compound concentration, a scratch assay was performed testing the effects of 
various concentration of Nocodazole [Fig. 3.13A]. Cell migration was inhibited in a 
concentration range of 10 to 200 nM [Fig. 3.13A]. Likewise, higher concentrations than 
200 nM inhibited cell migration but additionally induced apoptosis. For further 
experiments, a concentration of 50 nM was used as a pronounced inhibition of migration 
[Fig. 3.13A], but no apoptotic cells were observed. In single cell tracking experiments the 
mean velocity was significantly reduced by 38 % [Fig. 3.13B]. The corresponding 
trajectories of an exemplary experiment are pictured in Fig. 3.13B. Cell morphology 
changed dramatically upon Nocodazole treatment, resulting in cells displaying a circular 
and unpolarized phenotype. Immuno-stainings of MTs revealed that 20 hours after 
Nocodazole treatment, MTs were disrupted in the periphery of the cell [Fig. 3.13C].  
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Fig. 3.14 Nocodazole reduces motility of HUVECs migrating in a 3D collagen I matrix but 
displays no effect on cells migrating in a 1D environment.  
(A) Mean velocity analysis of HUVECs in 1D after treatment with 50 nM Nocodazole and 
corresponding control. (B) Mean velocity analysis of HUVECs in 3D after treatment with 50 nM 
Nocodazole and corresponding trajectories from single representative experiment. n = 3. 
Mean ± SEM. t-test; p***<0.001, n.s. = not significant. 
In the 1D system a disruption of MTs structure was induced in the periphery of the cell, 
near the leading edge by Nocodazole treatment (data not shown). However, observed 
effects were not as pronounced as in 2D. Migration experiments carried out on narrow 
migration tracks (1D) showed no significant effect in regard to mean velocity [Fig. 3.14A].  
In collagen I gels (3D), treatment with 50 nM Nocodazole led to a decreased mean 
velocity (by 49 %) [Fig. 3.14B, left panel] as visualized by the corresponding cell 
trajectories [Fig. 3.14B, right panel]. After treatment, cells failed to elongate along 
collagen fibers and displayed an un-polarized, mostly multiaxial phenotype.  
 
 3.1.11 The Rac1 inhibitor NSC23677 reduces motility of cells in 2D, but not in 1D 
and 3D systems 
As Rac1 is one of the most important regulators of cell motility, the Rac1 inhibitor 
NSC23677 was used in a concentration of 50 µM, in order to elucidate the role of Rac1 in 
cell migration in 1D, 2D, and 3D systems. HUVECs migrating on flat surfaces (2D) 
showed a highly significant reduction of mean velocity after treatment with this inhibitor 
[Fig. 3.15A]. The corresponding trajectories from a single experiment are pictured in 
Fig. 3.15B. In contrast to the observation of cells in 2D, the migration behavior of cells in 
1D was mildly but consistent altered upon Rac1 inhibition. A slight but significant reduction 
of mean velocity was observed [Fig. 3.16A]. Likewise, the behavior of 3D migrating cells 
was examined in more detail. In 3D, cells did not react very pronounced to Rac1 inhibition 
in regard to mean velocity as it was observed for migrating cells in 1D [Fig. 3.16B].  
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Fig. 3.15 The Rac1 inhibitor NSC23766 reduces motility of HUVECs migrating in 2D. 
(A) Mean velocity analysis of HUVECs in 2D after treatment with 50 µM NSC23766 and 
corresponding control. (B) Trajectories from a single representative experiment of HUVECs treated 
with 50 µM NSC23766. n = 3. Mean ± SEM. t-test; p***<0.001. 
Fig. 3.16 The Rac1 inhibitor NSC23766 does not influence motility of HUVECs in the 1D 
environment and in a 3D collagen I matrix. 
(A) Mean velocity analysis of HUVECs in 1D after treatment with 50 µM NSC23766 and 
corresponding control. (B) Mean velocity analysis of HUVECs in 1D after treatment with 50 µM 
NSC23766 and corresponding control. Trajectories are from a single representative experiment 
cells. n = 3. Mean ± SEM. t-test; p*<0.001 n.s. = not significant.  
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Fig. 3.17 Theory of tip cell formation combined with structured surfaces.  
(A) Schematic representation of the theoretical background of tip cell formation (B) Geometry of 
the pattern used for tip cell formation studies (C) Geometry displayed in (B) brought to a surface by 
micro contact printing using DyLight488 labeled fibronectin. Bar equals 50 µm. 
3.2 Closing the gap between in vivo and in silico - a novel approach of 
tip cell formation studies 
3.2.1 The theory of tip cell formation combined with structured surfaces 
Beside other factors, in theory, angiogenic sprouting requires the dynamic establishment 
of tip cells. These cells contain a specific set of receptors on their surface which are 
necessary to lead a sprout towards a hypoxic area (introduced in section 2.4). Basically, 
the formation of tip cells depends on the amount of cell-cell contacts, as the regulation of 
tip cell/stalk cell selection is Notch signaling dependent (Blanco and Gerhardt 2013) 
[Fig. 3.17A]. In this study, specific micro-structures were designed, harboring areas where 
cells are either able to develop a high amount or a limited number of cell-cell contacts 
[Fig. 3.17B]. Additionally, a branch was included in the geometry, which forces one 
specific cell to have exclusively one cell-cell contact in contrast to the other cells of the 
population [Fig. 3.17B]. Micro-contact printing was performed with labeled fibronectin in 
order to estimate and therefore guarantee the quality of the protein patterns [Fig. 3.17C]. 
The aim of this project was the establishment and characterization of a system which 
closes the gap between theoretic modeling and highly complex in vivo experiments. As 
VEGFR2 (Kdr) is the most prominent marker of tip cells, VEGFR2 regulation was 
evaluated for a cell population on the previously described pattern.  
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3.2.2 Regulation of VEGFR2 matches the theoretical background of tip and stalk cell 
formation 
To evaluate the impact of our microstructures on VEGFR2 expression, cells were seeded 
on the micro-patterns as introduced in Fig. 3.17. One day after seeding the VEGFR2 
protein level of the cells was variable within the cell population on the micro-pattern [Fig. 
3.18]. In order to differentiate between cells used for the quantification, cells were stained 
for VE-cadherin which is mainly localized in the cell-cell contact areas. Cells expressing a 
high level of VEGFR2 always displayed a high amount of cytosolic VE-cadherin 
[Fig. 3.18, left panel]. It was observed that VEGFR2 expression was quite evenly 
distributed over the micro-pattern and can be found to a very high extend in the pattern 
branch [Fig. 3.18, right panel]. Seven days after cell cultivation this situation changed 
drastically, as only few cells possessed a high VEGFR2 level. VEGFR2 expressing cells 
were predominantly located in the areas allowing for a low number of cell-cell contacts 
[Fig. 3.18].  
 
3.2.3 VEGFR2 regulation in artificial tip and stalk cells is Notch signaling dependent 
As a differential regulation of VEGFR2 expression levels was observed on micro-patterns, 
depending on the relative cell position, it was investigated if it is possible to block this 
behavior with the Notch signaling inhibitor dibenzazepine (DBZ). Cells in the tip position, 
possessing only one cell-cell contact were classified as a tip cell (TC) [Fig. 3.19A]. Cells 
Fig. 3.18 Micro-patterns allow for modification of VEGFR2 expression patterns. 
Immuno-stainings of HUVECs seeded on micro-patterns (250x250 µm squares with 150 µm long 
and 10 µm wide branches). VEGFR2 heat map was created by adding up several images of 
VEGFR2 immuno-stainings. Subsequently, the intensity was encoded in false colors. Images were 
acquired with a Leica SP8 confocal microscope. Bars equal 100 µm.  
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in direct contact to the tip cell were classified as a stalk cells (SC) [Fig. 3.19A]. To 
differentiate between single cells in intensity quantification, the cell-cell contact marker 
VE-Cadherin and VEGFR2 were co-stained. Intensity quantification without using DBZ 
revealed that tip cells expressed higher VEGFR2 levels compared to their corresponding 
stalk cells (negative value in transformed ratios; value of zero means no difference 
between tip and stalk cells, positive value means stalk cells possess more VEGFR2 
intensity) [Fig. 3.19B]. This behavior was blocked by using DBZ, as treated cells showed 
a nearly equal expression of VEGFR2 between tip and stalk cells [Fig. 3.19B]. To prove 
that Notch signaling was inhibited within the observation time frame of 24 hours, a 
Western Blot analysis was performed for VEGFR2 and NICD, the cleaved and active form 
of Notch. The VEGFR2 expression levels in treated and control cells remained equal, 
while NICD was reduced upon treatment with 10 µM DBZ [Fig. 3.19C]. 
 
 
 
Fig. 3.19 VEGFR2 regulation in 
artificial tip and stalk cells is 
dependent on Notch signaling. 
(A) Exemplary images of HUVECs on 
microstructures stained for 
VE-Cadherin and VEGFR2. TC = Tip 
cell; SC = Stalk cell. (B) Log10 
transformed VEGFR2 expression 
ratios of TCs and corresponding stalk 
cells. Ratio > 0 means stalk cells 
express more VEGFR2. Ratio < 0 
means tip cells express more 
VEGFR2. n = 3 (C) Western Blot 
analysis of HUVECs treated with 
10 µM DBZ and analyzed for NICD 
and VEGFR2. Beta-tubulin served as 
a loading control  
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4. Discussion 
4.1 Micro-tracks as a model to study endothelial cell migration 
4.1.1 Confined protein micro-tracks impact endothelial cell architecture 
In all experiments of this study, cell shape and thus the actin cytoskeleton of ECs changed 
drastically with reduction of micro-track width [Fig. 3.1B]. In contrast to the observation of 
aligned stress fibers on rectangular shaped micro-patterns by others (Roca-Cusachs et al. 
2008), cells in the experiments of this study formed pronounced cortical actin fibers and 
displayed a reduced stress fiber content with decreasing track width (Fig. 3.1B). The 
different observations are probably due to the different micro-pattern dimensions used in 
both studies. Likely, the reduced stress fiber content affects the g-actin to f-actin ratio 
within a cell in the 1D system in comparison to cells in 2D, which display a large amount 
of stress fibers [Fig. 3.7A]. The outcome of this ratio alteration might affect gene 
expression via actin sensitive pathways like the myocardin-related transcription factor 
(MRTF) pathway (Medjkane et al. 2009). Likewise, it is conceivable that stress fibers of 
cells on narrow tracks are bundled into cortical actin, changing their cellular localization 
with an increasing degree of confinement. This rearrangement has to be proven and can 
be investigated by using micro-patterns providing 1D to 2D transitions. The decreased 
spreading area on 3 µm wide tracks resulted in a more 3D-like morphology of the actin 
cytoskeleton and a pronounced membrane curvature as verified by cross section analysis 
[Fig. 3.8B]. This might have various molecular effects on the cell. For example it has been 
shown that GEFs and GAPs containing curvature sensing F-BAR domains (Heath and 
Insall 2008) are able to modulate Rac1 signaling and thus affect cell spreading and 
migration (de Kreuk et al. 2011). Moreover, the high amount of cortical actin is potentially 
induced by membrane curvature through F-BAR domain containing proteins influencing 
actin polymerization via N-WASP (Takano et al. 2008).  
The pronounced cortical actin bundles of stretched endothelial cells on 3 µm wide tracks 
are responsible for nucleus deformation and altered chromatin condensation as described 
in this study [Fig. 3.3] and in a previous one (Versaevel et al. 2012). Nucleus deformation 
is the limiting factor for migration through confined 3D environments, as it is up to ten 
times stiffer than the residual components of a cell (Wolf et al. 2013). Both alteration of 
chromatin condensation as well as the high tensional stress exerted to the nucleus might 
affect gene transcription in the 1D setting (Pajerowski et al. 2007). Interestingly nuclei of 
cells on 30 µm wide tracks displayed a slightly stretched morphology as proven by shape 
factor analysis [Fig.3.3]. Nuclei of cells on 30 µm wide tracks are not subject of 
compression by cortical actin bundles as observed for cells on 3 µm wide tracks. 
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However, the deformation of the nucleus can possibly be explained through the alignment 
of actin [Fig. 3.1B] or microtubules [Fig. 3.2], as both are physically connected to the 
nucleus (Reinsch and Gönczy 1998; Dupin et al. 2011). In conclusion, micro-patterns are 
a great and simple tool to address questions of nucleus deformation and to investigate the 
underlying mechanisms. 
The findings about Golgi and centrosome orientation on micro-structures [Fig. 3.2] were 
partly in accordance to other studies. On 30 µm wide tracks, a lateral assembly of the 
Golgi and the centrosomes was observed, pointing into the direction of the cell repellent 
surface. Lateral assembly of the Golgi on broad micro-patterns has been described for 
fibroblasts (Chen et al. 2013), but was still unknown for the centrosome to my knowledge. 
On 3 µm wide tracks, the position of the Golgi remained laterally to the nucleus, while the 
centrosome shifted to a sub-terminal position near the trailing edge [Fig. 3.2]. This is in 
contrast to another study performed with Bsc1 cells where the Golgi was also oriented 
behind the nucleus on thin migration tracks (Pouthas et al. 2008). However, the degree of 
confinement might play a pivotal role in this aspect as different migration track dimensions 
where used. The observed changes of centrosome orientation was in line with 
observations for other cell types like fibroblasts (Doyle et al. 2009) or the previously 
mentioned Bsc1 cells (Pouthas et al. 2008). In general, centrosomes and Golgi complexes 
orientate towards the leading edge in cells migrating in 2D environments 
(Yvon et al. 2002; Etienne-Manneville 2004). The findings of this study strengthened the 
role of spatial confinement as an important regulator for the orientation of the Golgi 
complex and centrosomes. It was demonstrated that confinement is more important for 
subcellular organization than the direction of movement. Moreover, the uncoupling of 
Golgi and centrosome upon confinement, and their independent spatial positioning as a 
reaction to confined spaces has not been described before. This provides a new insight 
into the diverse impacts of confinement on individual cell components. 
 
4.1.2 A matter of adhesion? – Endothelial cells migrate less efficient on narrow 
micro-tracks 
Migration velocity on 3 µm wide micro-tracks was slower in comparison to 2D cell 
migration and to migration on wider micro-tracks [Fig. 3.4A]. This is in contrast to a study 
using NIH3T3 fibroblasts, where an increased velocity of cells migrating in 1D, compared 
to cells migrating in 2D, was demonstrated (Doyle et al. 2009). Some studies investigated 
the migration velocity of ECs upon different migration track widths but are contradictory to 
each other, either providing evidence for a correlation (Lei et al. 2012 ) or excluding a 
possible relation (S Li et al. 2001). However, only few ECs were analyzed in the two 
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mentioned studies, providing no basis for a good statistic. Additionally, other substrate 
dimensions were used in both studies. The findings of this study are in line with previous 
data describing a coupling of cell mean velocity and persistence of a cell (Maiuri et al. 
2012; Maiuri et al. 2015). This correlation is seen by the decreasing directionality with 
decreasing track width [Fig. 3.4C]. Since mean velocity is a parameter comprising the 
persistence of migration, and since frequent changes of run direction were observed on 
the thin lines, consequently run velocity and persistence times were analyzed with a 
bimodal change point analysis (in cooperation with Prof. Joachim Rädler, LMU Munich). 
Both parameters were in line with the conventional trajectory analysis [Fig. 3.4G-I], further 
supporting the assumption of a correlation of cell velocity and persistence of movement. 
As a decreased spreading area was observed with decreasing track width [Fig. 3.4D], we 
suggested that a low adhesive environment might contribute to the low persistence of 
cells on narrow migration tracks. On narrow micro-tracks membrane blebs were observed 
as a dynamic reaction to the provided environment (mainly on 3 µm wide tracks but also 
on 10 µm wide tracks). This phenomenon was not observed on 20 µm and 30 µm wide 
tracks. As membrane blebbing is a reaction to low adhesiveness, the low directionality on 
thin tracks is likely a consequence of the frequent losses of polarization resulting in 
frequent changes in direction. These findings were underlined by the recovery of 
persistence after Blebbistatin treatment. An increased spreading area as well as a 
significantly higher directionality was observed for these cells [Fig. 3.6E]. Kymographic 
analysis showed that protrusion activity in cells on 3 µm wide tracks was much higher and 
uncoordinated compared to cells on 30 µm wide tracks [Fig. 3.4E-F]. This uncoordinated 
movement possibly plays a role in the frequent directional changes. Further, the 
uncoordinated protrusions of cells in 1D provide an indication that focal adhesion 
dynamics change in response to the 1D environment as it has been described for 
fibroblasts (Doyle et al. 2012). Further investigations need to be done and will provide 
more information about protrusion dynamics of ECs in restricted environments. 
 
4.1.3 HUVECs migrating in 1D share morphological similarities with HUVECs 
migrating in 3D collagen I matrices 
The major aim of this study was the comparison of migration behavior between ECs 
migrating on micro-tracks, with ECs migrating in fibrillary collagen I matrices, and ECs 
migrating in the classical2D cell culture system. The most striking similarities were the 
absence of cytosolic stress fibers and the presence of cells displaying membrane blebs in 
both 1D and 3D systems [Fig. 3.7]. The formation of membrane blebs will be discussed in 
more detail in section 4.1.5. We assume that stress fibers are not missing in the 3D setup 
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but built the pronounced cortical actin, a phenomenon that was also observed in the 1D 
system. Likewise, in 3D environments the g-actin to f-actin ratio in cell is altered in 
comparison to cells in the 2D system, as previously discussed before for cells in the 1D 
setting.  
During this thesis additional approaches were made to compare cell architecture between 
1D, 2D, and 3D systems. Preliminary results showed that Golgi orientation in 3D 
environments (data not shown) is comparable to the Golgi orientation of cells on 1D 
micro-structures [Fig. 3.2]. This underlines the data that direction of migration is not the 
essential factor for Golgi positioning in the cell. Taken together, HUVECs migrating in 1D 
and 3D systems have common characteristics regarding actin cytoskeleton, membrane 
blebs, and Golgi orientation 
 
4.1.4 Impact of contractility in 2D, 1D, and 3D - Contractility as a fundamental 
regulator of cellular shape, adhesion, and persistence 
Switching between different kinds of cell protrusions (lamellipodia and blebs) is thought to 
be favorable for cell motility as cells can migrate more efficiently through complex 3D 
environments (Friedl 2004; Friedl and Wolf 2010; Friedl et al. 2012). However, most of the 
studies focusing on bleb to lamellipodia transition use Walker 256 carcinosarcoma cells 
(Bergert et al. 2012), or dictyostelium (Yoshida and Soldati 2006). In ECs, the formation of 
membrane blebs has exclusively been described in the context of cell death or spreading 
to date (Norman et al. 2011). Beside cortical tension (Charras and Paluch 2008; Tinevez 
et al. 2009), loss of cellular adhesion has been discussed as a potential reason for 
membrane blebbing (Bergert et al. 2012). Moreover, the impact of membrane curvature 
has been shown to influence bleb formation in dictyostelium (Tyson et al. 2014). All these 
mentioned parameters could potentially play a role in the experiments of this study, as a 
reduced spreading area on narrow micro-tracks was observed [Fig. 3.5C] as well as a 
high membrane curvature which was proven by cross section profiles [Fig. 3.7B]. Here, 
membrane blebbing of ECs in 1D and 3D in phases of contraction and orientation was 
described [Fig. 3.5; Fig. 3.6; Fig 3.9]. Thus, at least in the 3D environment, the formation 
of membrane blebs is interpreted as a dynamic biological reaction to a non-homogenous 
environment. A summary of the complex connections between adhesion, contractility, 
persistence, velocity, and cellular shape in 1D, 2D, and 3D settings, based on the 
experiments in this study, are displayed in Fig. 4.1. 
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Fig. 4.1 Schematic overview of the connections between contractility, cell spreading, 
directionality, and velocity in infinite (2D) and restricted environments (1D and 3D). 
(A) Connection of migration parameters in 2D. The spreading area does not change with lower 
contractility. Cell shapes changes with the contractility level. (B) Connection of migration 
parameters in 1D and 3D. In contrast to 2D, cell spreading is enhanced with reduction of 
contractility and cells elongated strongly in both systems. In both 1D and 3D systems, rounded 
blebbing cells occur in high contractile states, which is in contrast to 2D. 
Single cell analysis in the 2D system revealed that cells move slightly faster but less 
persistent upon contractility inhibition with Blebbistatin (Fig. 3.6D - E). The low 
persistence observed in the experiments was caused by the loss of a single lamellipodium 
and the formation of uncontrolled protrusions in all directions [Fig. 3.6C; Movie S5]. 
Enhancement of contractility by Calyculin A caused a reduction of both velocity and 
persistence [Fig. 3.6], probably through the failure of an efficient coordination of the 
migration cycle. Cells displayed a more circular phenotype and had been immobile after 
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Calyculin A stimulation. Treatment with higher concentrations of Calyculin A led to a loss 
of adhesion in the 2D system. In contrast Blebbistatin treatment did not affect adhesion in 
the 2D system [Fig. 3.6G]. This was in contrast to the 1D system and presumably likewise 
to the 3D system, where Blebbistatin lead to an increased adhesion area as discussed 
later. These observations allow the conclusion that the 2D system is infinite as contractility 
inhibition, and thus softening of the cell does not promote cell spreading [Fig. 4.1A]. 
Moreover, we concluded that velocity in 2D environments behaves inversely proportional 
to contractility, while directionality is diminished in both high and low contractile states 
[Fig. 4.1A]. 
Interestingly, the treatment with Blebbistatin of cells on 3 µm wide tracks influences the 
universal coupling between cell speed and persistence as described before (Maiuri et al. 
2015), as both parameters are regulated separately [Fig. 3.5]. The increased persistence 
achieved with Blebbistatin treatment was associated with an increased spreading area in 
the 1D system (Fig. 3.5E). This allowed the classification of the 1D system as low 
adhesive (or not infinite) [Fig. 4.1]. The lower velocity in the 1D system upon Blebbistatin 
treatment is explained by inefficient trailing edge retraction or by changes in adhesion 
dynamics as described before for fibrillary environments (Doyle et al. 2012). To 
discriminate between these two possibilities, the effect of Blebbistatin on velocity has to 
be investigated further in future experiments. In contrast to the uncontrolled protrusions 
observed in 2D, 1D migrating cells elongated strongly upon Blebbistatin treatment [Fig. 
3.5F]. The lack of lateral protrusions is caused by the lateral restriction which the cells 
face in the 1D setting. The massive cell elongation might have two different reasons: 
firstly, myosin II inhibition by Blebbistatin treatment makes the cell softer (Wakatsuki et al. 
2003), leading to an increased spreading area and therefore to an elongated phenotype. 
Secondly, the decreased myosin II activity might inhibit the retraction of the cellular 
protrusions possibly leading to a disproportion of pushing forces (through actin 
polymerization) and retracting forces (contractility mediated) and thus resulting in 
elongated cell protrusions.  
The Calyculin A treatment of cells migrating on 3 µm wide tracks caused a reduction of 
cellular adhesion, and thus an enhancement of blebbing [Fig. 3.5]. It was shown that 
cellular velocity is decreased after Calyculin A treatment in the 1D system, leading to the 
assumption that velocity is diminished in both high and low contractile states [Fig. 4.1]. 
Analysis of directionality in 1D showed only a slight trend of reduction after Calyculin A 
treatment, even though a high number of bleb harboring cells were observed in 
comparison to untreated cells [Fig. 3.5F]. However, a contractile response was induced, 
and cells which were highly contractile and thus low persistent might have been lost due 
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to loss of adhesion in these experiments [Fig. 3.5]. In line with the findings that reduction 
of track width and thus reduction of spreading area leads to diminished persistence in 
migration [Fig. 3.4], we conclude that directionality and adhesion of ECs is inversely 
proportional to contractility in the described 1D system. This observation is in contrast to 
the 2D environment [Fig. 4.1B].  
ECs migrating in 3D switched between an elongated migration mode and a roundish bleb 
based orientation mode [Fig. 3.9; Movie S7]. Treatment with both Blebbistatin and 
Calyculin A revealed the same correlation between contractility and velocity/directionality 
as described for the 1D environment previously [Fig. 4.1B]. Treatment with Blebbistatin 
resulted in massive cell elongation, as seen for the 1D environment, concluding that the 
adhesion area likewise increases in the 3D setting [Fig. 3.9F; Movie S8]. Moreover, as no 
lateral protrusions were observed upon Blebbistatin treatment, we conclude that the 3D 
migration along collagen I fibers is laterally restricted, as described for the 1D setting. 
Cells treated with Blebbistatin moved slower but highly directed in the 3D environment. 
Based on the observations in 1D the increase of directionality upon contractility inhibition 
in 3D might be caused by two different factors. Firstly, the missing bleb-based 
reorientation and thus missing re-elongation along differently oriented fibers stabilizes the 
direction of migration. Secondly, the stabilization of a uni-axial phenotype by increased 
spreading and longer protrusions. The stabilization of a uniaxial phenotype is caused by 
the lateral restricted environment as described for the 1D setting. Likewise, also in the 3D 
setting an increased spreading area as well as a disproportion of pushing and retracting 
forces might be the reason for the cell elongation observed in the 3D setting. The 
decrease of velocity in 3D is probably caused by reduced trailing edge retraction as well 
as altered focal adhesion dynamics (Doyle et al. 2015). After treatment with Calyculin A, 
cells reacted with both diminished velocity and directionality. These effects are caused by 
massive switching to the round blebbing mode with permanent reorientation and adhesion 
to different fibers [Fig. 3.9; Movie S9]. Summed up, in 3D environments directionality and 
adhesion is inversely proportional to contractility as in the 1D system. In contrast to the 
observations made for cells migrating in the 2D system, cells moved slower in both high 
and low contractile states in 3D environments [Fig 4.1B]. 
 
4.1.5 Impact of microtubule and actin disruption on endothelial cell motility in 1D, 
2D, and 3D systems 
The inhibitors used in this study were Cytochalasin D, an actin disrupting agent, and the 
Ezrin inhibitor NSC668394 disrupting actin tethering to the membrane. Cells displayed a 
good response to both inhibitors in 2D as migration was inhibited in both scratch assays 
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and single cell experiments upon treatment [Fig. 3.10]. Likewise in 1D and 3D, migration 
was strongly inhibited, as mean velocities were significantly reduced in all settings upon 
treatment with both inhibitors [Fig. 3.10; Fig. 3.11]. These observations displayed the 
major role of the actin cytoskeleton for EC migration in all three systems. However slight 
differences were observed between the systems regarding the response of cells to 
compound treatment. While cells migrating in 2D and 3D responded to both inhibitors in 
the same way, cells migrating in 1D responded much stronger to the Ezrin inhibitor. This 
suggests that members of the Ezrin/Radixin/Moesin family (Tsukita and Yonemura 1999) 
play a pivotal role in migration in restricted environments.  
In contrast to this, the microtubule disrupting agent Nocodazole displayed a different 
impact in 1D, 2D, and 3D settings. In 2D and 3D, mean velocity was significantly reduced 
[Fig. 3.13; Fig. 3.14], while mean velocity of 1D migrating cells was not influenced upon 
treatment [Fig. 3.14]. In the 2D system cells displayed a more rounded morphology and 
started to tumble after Nocodazole treatment, while cells in 3D failed to elongate along the 
collagen fibers. The observations for 3D are in line with another study (Doyle et al. 2009). 
As MTs pay a pivotal role in cell migration (Etienne-Manneville 2013), the cellular 
reactions in 2D and 3D are plausible. However, the reaction of 1D migrating cell upon MT 
disruption is less understood. It has been described that MT are responsible for cellular 
contractility (Kaverina and Straube 2011), and that MT disrupting agents cause a 
contractile response (Danowski 1989). This contractile response is provoked by the 
release of the RhoA activating factor GEF-H1 from MTs upon Nocodazole treatment 
(Chang et al. 2008), and potentially leads to loss of a high contractile cell population in the 
1D setting directly after Nocodazole treatment due to loss of adhesion. The same is 
suspected for Calyculin A treatment. Indeed, cellular reactions of Nocodazole and the 
contractility inducing agent Calyculin A have been very similar. As the switch between 
blebbing and non-blebbing mode was found to be contractility-dependent (discussed in 
section 4.1.6), it would be interesting to know if Nocodazole also induces blebbing and 
reduces adhesion area in both 1D and 3D systems.  
Likewise, it is conceivable that cells migrating in 1D are resistant to the specific 
concentration of Nocodazole used for 1D migration experiments. Further experiments 
need to be done using various concentrations of Nocodazole, as well as other MT 
disrupting agents in order to elucidate the role of MTs in 1D migration.  
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4.1.6 HUVEC migration is not diminished by Rac1 inhibition in 1D and 3D  
Rac1 is an important regulator of cell motility as it is crucial for lamellipodial formation and 
actin reorganization in general (see section 2.3.1). The Rac1 inhibitor NSC23766 
interferes with the binding of Rac1 to its GEFs Trio and Tiam1 (Gao et al. 2004), thereby 
inhibiting Rac1 activation. However, it has been shown that it does not interfere with Vav 
(Gao et al. 2004), a GEF which was shown to be activated upon VEGFR2 signaling in 
endothelial cells promoting Rac1 activation (Garrett et al. 2007). Likewise Trio and Tiam1 
have been described as Rac1 regulating factors in endothelial cells (Birukova et al. 2007; 
Timmerman et al. 2015). Treatment with the Rac1 inhibitor NSC23766 led to completely 
different results in 1D, 2D and 3D as it inhibited cell migration only in the 2D setting 
[Fig. 3.15; Fig. 3.16]. It is possible that spatial restriction and the low adhesiveness in 1D 
and 3D led to different expression of the previous described GEFs. For example, a higher 
level of Vav2 and low levels of Trio and Tiam1 could have led to a cellular resistance 
towards the inhibitor as it only blocks interaction between Rac1 and Trio/Tiam1. Likewise 
it is conceivable that Rac1 plays a minor role for cells migrating in the 1D and 3D systems 
compared to cells migrating in the 2D system. However, the molecular mechanism 
underlying this observation has to be investigated to certainly explain the observed 
differences. 
 
4.1.7 Summary– Is 1D migration a sufficient model for 3D migration and an 
advantage over 2D migration?  
The major findings about 1D, 2D, and 3D migration obtained in this study are visually 
summarized in Fig 4.2. Taken together, the migration behavior of cells in 3D has a higher 
degree of similarity to the cell migration behavior in the 1D environment compared to the 
migration behavior of cells in the 2D environment. Thus the 1D migration system harbors 
an advantage over the classical cell culture systems as it displays in vivo more closely. 
HUVECs in all analyzed settings reacted similar to the disruption of the actin cytoskeleton 
and to inhibition of Ezrin, concluding that actin cytoskeleton integrity is of crucial 
importance in endothelial cell migration, despite the specific environments. MT disruption 
had no effect on cells in 1D, but a pronounced effect in 2D and 3D, respectively. Rac1 
inhibition exclusively had an effect in the 2D system, but not in 1D and 3D respectively. In 
line with this, cells migrating in 1D showed a similar actin cytoskeleton morphology as 
cells migrating in 3D, which was in contrast to the cytoskeleton morphology displayed by 
cells migrating in 2D. 
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Fig. 4.2 Comprehensive comparison of cellular behavior in 1D, 2D, and 3D environments.  
2D systems provide an infinite and highly adhesive environment while 1D and 3D systems provide 
a low adhesive and lateral restricted environment. While 2D migrating cells display a 
lamellipodium-based migration without switching protrusions, 1D and 3D migrating cells switch 
between a lamellipodium-based and a bleb-based morphology. The findings for all three settings 
are listed next to the schematics of the cellular morphologies. Nuclei are displayed in blue. 
Explanation of the observations can be found in the text. 
The main differences in 1D and 3D systems compared to the 2D system upon changes in 
contractility were identified in both low and high contractile states. In high contractile 
states, the morphological transitions (switch of protrusions) in both 1D and 3D systems 
were the most prominent observation. No drastic differences of the migration parameters 
velocity and directionality were observed in comparison to the 2D setting [Fig. 4.1]. In 
contrast to this, Blebbistatin treatment and thus the reduction of contractility led to similar 
changes in migration parameter in 1D and 3D settings and an opposite effect in the 2D 
setting. This suggests, that studies using traditional 2D cell migration systems, might 
underestimate reactions of cells in low contractile states as the spreading area is infinite 
and not laterally restricted in contrast to 1D and 3D [Fig. 4.1]. Thus, the migration 
behavior on micro-tracks mimics the in vivo situation better, as it captures the whole 
dynamic range of morphological transitions, including migration behavior in low contractile 
states [Fig. 4.2]. 
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The technical advantages of a 1D system over a 2D system are a great benefit for 
cell-based studies as the predictive value is higher for the in vivo situation, and thus 
facilitates the translation to animal experiments. Likewise the possibility to perform 
high-throughput assays (e.g. with automated tracking), the improved microscopy 
conditions compared to 3D, as well as the high reproducibility and versatility of this system 
are favorable for future cell-based studies. 
 
4.1.8 Outlook – Future perspectives  
This study paved the way for a reliable 3D migration model even though many unsolved 
questions remain and several possibilities of optimization exist. A good starting point for 
further experiments is the investigation of the resistance of 1D and 3D migrating cells 
towards the Rac1 inhibitor NSC23766. As this inhibitor disrupts the binding to GEFs and 
not to the effectors it will be interesting if the expression levels of Trio and Tiam1 change 
upon treatment. Rac1, as a central player in regulation of migration, is expected to be 
likewise important in 1D and 3D migration systems. However an experimental proof is still 
missing.  
The putative resistance of migrating cells in 1D upon Nocodazole treatment might be due 
to a high contractile response as described in section 4.1.5. A differential experimental 
setup with a pre-incubation of the cells with a low concentration of Blebbistatin might 
counteract these reactions and the impact of microtubules on migration can be analyzed 
more reliably. However, it has to be taken into account that Blebbistatin influences both 
contractility and velocity, making it absolutely necessary to analyze both parameters in 
these experiments very carefully. 
Blebbistatin treatment stabilizes the highly directed migration phenotype of cells migrating 
in the 1D and 3D systems. Quantitative kymographic analyses of cells treated with 
Blebbistatin will reveal underlying regulatory mechanisms e.g. the disproportion of pushing 
and retracting forces as proposed in section 4.1.4.  
Another question which has not been addressed in this study is the dependency of 
migration on the ECM protein density on the protein tracks. Due to technical limitations, 
this parameter cannot be carefully controlled in micro-contact printing. However, this is 
achievable using other techniques like plasma-induced patterning (Hsieh et al. 2009), 
where protein concentrations at the surface can be directly influenced.   
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Another main difference between the current 1D and 3D migration model is the elasticity 
of the substrate. While the 1D migration experiments were performed on relatively rigid 
plastic surfaces, 3D migrating cells faced an elastic and deformable collagen environment. 
To date protein structures can be brought onto soft surfaces like polyacrylamide gels 
(Yu et al. 2012). This allows the imitation of the elastic environment of 3D systems and its 
combination with the lateral restriction and low adhesiveness provided by the 
micro-tracks. As cells spread less on soft substrates (Cui et al. 2015), the cellular 
reactions in regard to migration but also to morphological switching are of great interest. 
Besides the experimental setups, there are some technical possibilities to enhance the 
model of 3D migration. 3 µm wide patterns were used as the thinnest migration tracks in 
this study. However, the technical limitation of micro-contact printing is in the range of 
500 nm, which is similar to the width of a collagen fiber of the collagen I gels used in this 
study [Fig. 3.8]. A single track of 500 nm might be too less adhesive for cellular 
attachment, but a network of thin 500 nm tracks on a surface possibly imitates a collagen 
network very closely. This setup would provide great possibilities for cell migration 
analyses, for example the investigation of decision-making processes, depending of 
constraint and homogeneity of the environment. 
 
4.2 Closing the gap between in vivo and in silico – A novel approach for tip 
cell formation studies 
4.2.1 VEGFR2 expression patterns on structured surfaces match the theoretical 
background of tip cell formation 
Tip cell formation is a process which is mainly dependent on cell-cell contacts (Blanco and 
Gerhardt 2013). The results of this study demonstrated that expression of VEGFR2, a 
prominent marker of tip cells is influenced by using micro-structured surfaces. Cells in the 
area providing a low number of cell-cell contacts, and especially in the branch of the 
structure displayed higher expression levels of VEGFR2 [Fig. 3.19], what is in line with the 
theoretical expectations for this approach [Fig. 3.17]. The differences in VEGFR2 
expression levels were blocked with the use of the gamma-secretase inhibitor DBZ, 
diminishing Notch signaling [Fig. 3.19]. This implies that VEGFR2 regulation in our model 
system is Notch signaling-dependent which is in line with previous in vivo observations 
and modeling approaches in silico. However, other diverse factors might contribute to this 
phenomenon. First of all, cell-cell contacts affect cell proliferation of endothelial cells. The 
findings in the studies about contact mediated inhibition of proliferation are contradictive to 
each other, as some groups found an inhibiting effect on proliferation 
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(e.g. Grazia Lampugnani et al. 2003), while another found an stimulating effect by using 
micro-patterns (Gray et al. 2008). Notable in the work of Gray and colleagues is the 
investigation of cell-cell contacts without changing the adhesion area. As adhesion area 
also affects proliferation of cells (Pirone et al. 2006), this is an important aspect often 
neglected in comparative studies. The changes in proliferative activity might influence 
VEGFR2 expression levels, an aspect that has to be investigated further, especially as the 
effect of VEGFR2 receptor expression differed between day one and day seven of cell 
cultivation [Fig. 3.18]. Another study, where a similar approach with epithelial cells was 
investigated, postulated a strong influence of intercellular mechano-transduction on the 
expression patterns of epithelial-mesenchymal transition (EMT) markers (Gomez et al. 
2010). This implies that mechanical differences in the inner and outer regions of the 
pattern potentially influence the expression patterns of VEGFR2 in the experiments of this 
study.  
 
4.2.2 Outlook – Possible applications for the introduced system 
As this system is in an early stage of development there are various possibilities for 
optimization and remaining open questions to answer. The advantages over current 
possibilities to investigate tip cell formation, like complex animal models, are enormous. 
The first step to make this model more straight forward, is the establishment of prospects 
for the live observations of gene expression. The current analysis of the data is time 
consuming as it is based on quantification of confocal images of immuno-stained cells. As 
HUVECs are primary cells, genetic manipulation is hardly feasible as they are short-living. 
Moreover, the use of immortalized HUVECs is problematic as it cannot be excluded 
whether they have lost endothelial-specific properties upon immortalization. A quick and 
easy approach of gene transcription analysis is currently under investigation in our 
laboratory, using the “Smart Flare®” technology in combination with micro-structured 
surfaces. This approach will enable the investigation of gene expression by a 
fluorescence-based microscopy method in a highly time-resolved manner.  
The huge advantage of investigating tip cell formation on micro-structures is the versatility 
of the technique, allowing for manipulation of cellular behavior. First of all, the geometry of 
the micro-structures is variable, providing high control over cell-cell contact interface of 
single cells. Cells can be trapped in the branch with molecular ratchets as described 
before (Mahmud et al. 2009). Thus, persistence of the cells in the tip cell position is 
controllable. Moreover, other processes are addressable with this system. For example, in 
our laboratory it was shown that MRTF signaling in endothelial changes drastically with 
the amount of cell-cell contacts (Florian Gegenfurtner, AK Vollmar, unpublished data). 
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Other processes, like the epithelial-mesenchymal transition (EMT) are Notch 
signaling-dependent (Wang et al. 2010) and can be investigated closely with the help of 
the introduced micro-structures. As micro-structures provide a highly controllable setting, 
this model in combination with live observations of gene expression will provide a powerful 
tool to obtain highly time resolved data, allowing to draw conclusions about the in vivo 
situation, and to provide data needed for theoretical modeling approaches.  
 
4.3 Conclusion - Models for angiogenesis on micro-structured surfaces 
This study proves that micro-structured surfaces are useful to model certain angiogenesis 
related processes in a highly controlled manner. Beside the similarities between EC 
migration in 1D and 3D highlighted in this study, a novel approach for tip cell formation 
studies revealed promising results. This study leads the way to more sophisticated models 
for angiogenesis related processes in the future and provides a novel view on endothelial 
cell biology.  
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5. Material and Methods 
5.1 Material 
5.1.1 Primary cells 
HUVECs (human umbilical vein endothelial cells) were purchased from PromoCell 
(Heidelberg, Germany). They are commonly used as primary model cells for the 
investigation of angiogenesis related processes (Crampton et al. 2007). In advance of 
every experiment, cells were checked for their morphology, contamination and overall 
condition with a transmitted light microscope.  
 
5.1.2 Bacteria 
Chemo-competent Escherichia coli cells 
Strain Genotype Reference 
 
DH5αF’ 
 
F’-, endA1, hsdR17 (rK-,mK+), 
supE44,thi1-, recA-, λ-, gyrA96, relA1 
 
 
(Hanahan 1983) 
 
5.1.3 Devices 
 
Table 1: Devices 
Device Manufacturer (name and headquarters) 
Blotting device BioRad, Hercules, CA, USA 
Cell counter Vi-Cell XR Beckmann & Coulter, Brea, CA, USA 
Cell Culture Incubator Hera Cell Heraeus, Hanau, Germany 
Centrifuge Megafuge Thermo Scientific, Waltham, MA, USA 
Centrifuge Mikro 220R  Hettich, Tuttlingen, Germany 
Centrifuge Rotina R46 Hettich, Tuttlingen, Germany 
Electrophorese chamber BioRad, Hercules, CA, USA 
Gel caster  BioRad, Hercules, CA, USA 
Heating Block Eppendorf, Hamburg, Germany 
Heating Cabinet Memmert, Schwabach, Germany 
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5.1.4 Chemicals and reagents 
All chemical used in this study were obtained in the highest purity grade. 
 
Table 2: Chemicals  
Chemical Manufacturer (name and headquarters) 
Acrylamide/Bisacrylamide Carl Roth, Karlsruhe, Germany 
Beta-mercaptoethanol Sigma-Aldrich, St. Louis, MO, USA 
Blebbistatin (-/-) Sigma-Aldrich, St. Louis, MO, USA 
Blotto solution Thermo Scientific, Waltham, MA, USA 
Bovine serum albumin (BSA) Sigma-Aldrich, St. Louis, MO, USA 
Bradford reagent BioRad, Heidelberg, Germany 
Calyculin A CalBiochem, San Diego, CA, USA 
Collagen G Biochrom AG, Berlin, Germany 
Incubation chamber microscope 1 Ibidi, Martinsried, Germany 
Incubation chamber microscope 2 Okolab, Pozzuoli, Italy 
Laminar Flow Hera Safe Heraeus, Hanau, Germany 
Laser writer ProtoLaser LPKF, Tualatin, OR, USA 
microscope incubation system 1 Ibidi, Martinsried, Germany 
microscope incubation system 2  Okolab, Pozzuoli, Italy 
Nano Drop Thermo Scientific, Waltham, MA, USA 
Photo Developer Curix 60 Afga, Mortsel, Belgium 
Plate Reader  Tecan, Männedorf, Switzerland 
Shaker Thermoshake (bacteria 
incubation) 
Gerhardt, Königswinter, Germany 
Shaker Vibrax (table top device) Ika, Staufen, Germany 
SP8 LSM confocal microscope Leica, Wetzlar, Germany 
Table Centrifuge Galaxy Mini VWR, Radnor, PA, USA 
Ti Eclipse wide-field microscope Nikon, Tokio, Japan 
UV/Ozone-Cleaner Novascan, Ames, MA, USA 
Water bath Haake C10 Thermo Scientific, Waltham, MA, USA 
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Complete Roche, Penzberg, Germany 
Cytochalasin D Sigma-Aldrich, St. Louis, MO, USA 
Dimethylsulfoxide (DMSO) Applichem, Darmstadt, Germany 
ECL reagent GE Lifesciences, Little Chalfont UK 
EGTA Applichem, Darmstadt, Germany 
Ezrin Inh. NSC6683894 Merck, Darmstadt, Germany 
Fibronectin Dow Corning, New York, NY, USA 
FluorSave mounting medium CalBiochem, Darmstadt, Germany 
Glutaraldehyde Fluka Biochem, Taufkirchen, Germany 
Glycin Applichem, Darmstadt, Germany 
Hoechst 33342 Sigma-Aldrich, St. Louis, MO, USA 
Kanamycin Sigma-Aldrich, St. Louis, MO, USA 
LB Agar powder Invitrogen, Carlsbad, CA, USA 
Mr-Dev600  Micro resist technology, Berlin, Germany 
NaBH4 Fluka Biochem, Taufkirchen, Germany 
Nocodazole Sigma-Aldrich, St. Louis, MO, USA 
Formaline Applichem, Darmstadt, Germany 
Polydimethylsiloxane (PDMS) Sylgard 
184 
Dow Corning, New York, NY, USA 
Poly-L-lysine-(2)-polyethyleneglycol 
(PLL-(2)-PEG) 
Surface Solutions, Dübendorf, Switzerland 
Rac1 Inhibitor NSC23766 CalBiochem, Darmstadt, Germany 
Rat tail collagen I Ibidi, Martinsried, Germany 
Rhodamine-phalloidin Sigma-Aldrich, St. Louis, MO, USA 
Sodium dodecyl sulfate (SDS) Carl Roth, Karlsruhe, Germany 
Sodium fluoride (NaF) Merck, Darmstadt, Germany 
Sodium orthovanadate (Na3VO4) ICN, Biomedicals, Aurora, OH, USA 
SU8 photo resist MicroChem, Westborough, MA, USA 
Tris base Carl Roth, Karlsruhe, Germany 
Tris hydrochloride Carl Roth, Karlsruhe, Germany 
Triton X-100 Sigma-Aldrich, St. Louis, MO, USA 
Tween 20 Carl Roth, Karlsruhe, Germany 
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5.1.5 Composition of solutions and buffers 
 
Table 3: Solutions and buffer composition 
Solution/Buffer Composition 
Brinkley buffer 5X 1 mM MgCl2, 1mM EGTA, 80mM PIPES 
Cell extraction buffer 20 % Brinkley buffer, 80% ddH2O, 4 mM 
EGTA, 0.5 % Triton X-100   
Electrophoresis buffer 10x 250 mM Tris, 2M glycine, 10 % SDS 
LB Agar 10 g/l Tryptone, 5 g/l NaCl, 5 g/l Yeast extract, 
15 g/ml Agar 
LB Medium 10 g/l Tryptone, 5 g/l NaCl, 5 g/l Yeast extract 
Lysis Buffer Tris/HCL 50 mM, NaCl 150 mM, 1 % Nonidet 
NP-40, 0.25 % sodium deoxycholate, 0.1 % 
SDS, 4 mM complete EDTA 
PBS-T PBS + 0.1% Tween 20 
Phosphate buffered saline (PBS) 137 mM NaCl, 2.7 mM KCl, 10 mM Na2KPO4, 
1,8 mM KH2PO4  
Phosphate buffered saline with 
Ca2+/Mg2+ 
137 mM NaCl, 2.7 mM KCl, 10 mM Na2KPO4, 
1,8 mM KH2PO4, 0.7 mM CaCl2, 0.5 mM MgCl2 
Polyacrylamide gels separation gel 10 % Acrylamamide/Bis 33 %, 375 mM Tris (pH 
8.8), 0.1 % SDS, 0.1 %TEMED, 0.05 % APS 
Polyacrylamide stacking gel 17 % Acrylamamide/Bis, 125 mM Tris (pH 
6.8), 0.1 % SDS, 0.1 % TEMED, 0.05 % APS  
SDS sample buffer 5x 20% glycerine, 10% SDS, 10% beta- 
mercaptoethanol, 0.05% bromphenolblue 
Tank buffer 10x 250 mM Tris, 1.92 M glycine  
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5.1.6 Cell culture medium and components 
 
Table 4: Cell culture media and components 
Medium Manufacturer (name and headquarters) 
Amphotericin B AppliChem, Darmstadt, Germany 
DMEM PAA, Pasching, Austria 
Endothelial basal medium 10X (ECBM) Promocell, Heidelberg, Germany 
Endothelial basal medium 1X (ECBM) Promocell, Heidelberg, Germany 
Endothelium growth medium (ECGM) Promocell, Heidelberg, Germany 
Endothelium growth medium (ECGM) Pelo, Planegg, Germany 
Fetal calf serum (FCS) PAA, Pasching, Austria 
M199 PAA, Pasching, Austria 
Penicillin/Streptomycin PAN Biotech, Aidenbach, Germany 
Trypsin/EDTA 10x PAN Biotech, Aidenbach, Germany 
 
5.1.7 Kits 
 
Table 5: Kits 
Software Manufacturer (name and headquarters) 
Plasmid preparation kit Qiagen, Venlo, Netherlands  
Protein labeling kit Thermo Scientific, Waltham, MA, USA 
Transfection kit HUVEC Targeting systems, El Cajon, CA, USA 
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5.1.8 Antibodies 
 
Table 6: Primary antibodies 
Name/Target Supplier Used dilutions  
Beta-tubulin #2146 Cell Signaling, Danvers, MA, USA 1:200  
Collagen I #34710 Abcam, Cambridge, UK 1:200  
Cortactin #3503 Cell Signaling, Danvers, MA, USA 1:200  
Fibronectin #73611 Santa Cruz, Dallas, TX, USA 1:200  
Gamma-tubulin #6557 Sigma, St. Louis, MO, USA 1:7000  
GM130 #12480 Cell Signaling, Danvers, MA, USA 1:200  
Integrin beta 1 #8978 Santa Cruz, Dallas, TX, USA 1:200  
NICD (Notch 1cleaved) #4147 Cell Signaling, Danvers, MA, USA 1:200  
Phospho-myosin light chain #3674 Cell Signaling, Danvers, MA, USA 1:200  
VE-Cadherin #6458 Santa Cruz, Dallas, TX, USA 1:200  
VEGFR2 #2479 Cell Signaling, Danvers, MA, USA 1:200  
 
Table 7: Secondary antibodies 
Name/Target Supplier Used dilutions  
Goat anti-rabbit Alexa Fluor488 Invitrogen, Carlsbad, CA, USA 1:400  
Goat anti-mouse Alexa Fluor488 Invitrogen, Carlsbad, CA, USA 1:400  
Goat anti-rabbit Alexa Fluor680 Invitrogen, Carlsbad, CA, USA 1:400  
Goat anti-mouse Alexa Fluor680 Invitrogen, Carlsbad, CA, USA 1:400  
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5.1.9 Plasmids 
 
Table 8: Plasmids 
Name Reference/Supplier 
Cortactin-GFP Addgene #50728 
LifeAct-RFP Ibidi, Martinried, Germany 
 
5.1.10 Software  
 
Table 9: Software 
Software Origin 
GraphPad Prism GraphPad Software, La Jolla, CA, USA 
ImageJ Open Source 
Inkscape Open Source 
LAS X Leica, Wetzlar, Germany 
MATLAB MathWorks, Natick, MA, USA 
NIS-Elements Nikon, Tokio, Japan 
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5.2 Methods 
5.2.1 Cell culture 
5.2.1.1 Cultivation of cells 
HUVECs were cultivated under sterile conditions with endothelial cell growth medium 
(ECGM) obtained from PromoCell or Pelo, supplemented with 1 % 
penicillin/streptavidin/amphotericin B and 10 % FCS. During this study medium suppliers 
were changed due to problems of proper cell growth and migration after using a new 
batch of medium. No changes in cellular behavior have been observed after changing the 
suppliers. For all experiments, cells were used in one of the passages #2 to #6. 
Cells were incubated at constantly at 37 °C under 5 % CO2 atmosphere. Prior to 
experiments and passaging, cells were covered with 1x trypsin/EDTA until cells detached. 
Subsequently, trypsin was inactivated by DMEM supplemented with 10 % fetal calf serum 
(FCS). Cells were pelleted by centrifugation at 1000 rpm for 5 min (RT). Subsequently the 
cell pellet was resuspended in ECGM and diluted to the desired cell concentrations for 
further usage in the various experimental procedures. 
 
5.2.1.2 Cryo-conservation and thawing of cells 
Spare HUVECs were frozen in liquid nitrogen and freshly thawed upon need. For 
cryo-conservation, cells were harvested as described above and diluted in freezing 
medium (20 % FCS, 10 % DMSO in M199) in a concentration of 2x106 cells/ml. 
Subsequently, cell solution was transferred into cryo-vials and immediately stored into 
liquid nitrogen. 
To thaw cells, cryo-vials containing the frozen cells were pre-warmed in a water bath to 
37 °C and immediately transferred into ECGM, for incubation either in a 25 cm2 or 75 cm2 
cell culture flask depending on the passage.  
 
5.2.1.3 Cell counting 
Cells were counted using a Beckman & Coulter ViCell cell counter. The amount of viable 
cells was taken for further calculation of desired cell concentrations in the different 
experimental setups. 
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5.2.2 Cell biological methods 
5.2.2.1 Transient Transfection 
HUVECs were seeded in a 6-well plate in a concentration of 0.25 x 106/well, 24 hours 
prior to transfection. For transfection routine, a HUVEC transfection kit (Targeting 
Systems, El Cajon, CA, USA) was used according to the manufacturers’ protocol. The 
transfection master-mix contained 1.5 µg purified plasmid-DNA, 15 µl peptide enhancer, 
and 5 µl Targefect in 1 ml DMEM without supplements. The master mix was incubated for 
25 minutes at 37 °C prior to transfection. Subsequently, cells were washed gently with 
pre-warmed PBS (+ Ca2+, Mg2+) twice, and transfection mix was added to the cell layer by 
pipetting. After 2 hours at 37 °C, the transfection mix was aspirated and cells were gently 
washed with pre-warmed PBS (+ Ca2+, Mg2+) twice. 16-20 hours after transfection, 
expression levels of transfected plasmid DNA were sufficient for further experimental 
procedures.  
 
5.2.2.2 Migration experiments 
5.2.2.2.1 Migration experiments on micro-patterns 
Structured surfaces for migration experiments were manufactured as described in the soft 
lithography section (see section 5.2.3). To visualize and therefore to ensure a high printing 
quality, a mixture containing 40 µg/ml unlabeled fibronectin and 10 µg/ml labeled 
fibronectin was used for micro contact printing (µCP). Fibronectin was labeled as 
described in section 5.2.6.5. Cells were seeded at a density of 25 x 103 cells per well in 
200 µl full growth medium. Subsequently cells were allowed to attach to the 
micro-patterns for 1.5 to 2 hours. Subsequently, cells were carefully washed with 
pre-warmed PBS (+ Ca2+, Mg2+) twice in order to remove unattached cells. All experiments 
were all performed in full growth medium. Prior to each experiment, fluorescence images 
were taken from all defined positions in order to ensure proper printing quality. 
Experiments were started 1 hour after treatment with the respective compound/inhibitor.  
 
5.2.2.2.2 Migration experiments on 2D surfaces 
2D migration experiments were performed using Ibidi chemotaxis slides without applying a 
chemotactic gradient or Ibidi 8-well slides. Cells were filled into the observation channel in 
a density of 3x106 cells/ml according to the manufactures instructions or seeded in an 
8-well slide in a concentration of 25 x 103 cells/well in 200 µl endothelial full growth 
medium. After 2 hours, cells have been settled down and adhered to the surface and the 
channel was flushed twice with basal medium. Subsequently, both reservoirs were filled 
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with full growth medium supplemented with 10 % FCS. In the 8-well slides, cells were 
carefully washed with pre-warmed PBS (+ Ca2+, Mg2+) twice in order to remove 
unattached cells, before adding full growth medium. The experiment was started 1 hour 
after compound/inhibitor treatment. 
 
5.2.2.2.3 Migration experiments in collagen I gels 
3D migration experiments were performed using Ibidi chemotaxis slides without applying a 
chemotactic gradient. Cells were embedded in a Collagen I gel as described in the 
following. 60 µl of commercially obtained rat Tail collagen I (stock solution 5mg/ml) was 
mixed with 20 µl of 10x endothelial basal medium (BM). 112 µl ultrapure sterile water, 
8 µl NaHCO3 and 50 µl 1x endothelial basal medium. All solutions were constantly 
incubated on ice during the procedure. 18x106 cells/ml were mixed with the gel and filled 
into the observation channel according to manufactures instructions. For polymerization 
the gel was incubated at 37 °C, 5 % CO2 for at least 30 minutes. Upon polymerization, 
both reservoirs were filled with full growth medium supplemented with 10 % FCS for all 
experiments. Experiments were started 2 hours after compound/inhibitor treatment, due to 
the longer diffusion time into the gel. 
 
5.2.2.2 Compound/Inhibitor treatment 
Inhibitor treatment of HUVECs was always performed without pre-incubation. Inhibitors 
were diluted to the desired stock concentrations according to the manufacturers’ protocol. 
The calculation of stock solutions was adjusted for every compound to reach a final 
solvent concentration of 0.1 % to 0.5 % (DMSO or H2O). Appropriate concentrations for 
each experiment were achieved by diluting the stock concentrations in endothelial full 
growth medium. For migration experiments in 8-well slides, 200 µl of full growth medium 
with the desired inhibitor concentration was applied to each well and experiments were 
started 1 hour later. For 3D experiments, both reservoirs were filled with ECGM containing 
the appropriate inhibitor concentration. 3D experiments were started 2 hours after 
treatment.  
 
5.2.2.3 Scratch assay (Wound healing assay) 
Scratch assays were performed in a 96-well plate format. Cells were seeded in a 
concentration of 0.45 x 106 cells/ml one day prior to the experiment, in order to achieve a 
confluent cell layer. After 24 hours, the scratch was applied in all 96 wells simultaneously 
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using a self-built device. Subsequently, cells were carefully washed with PBS 
(+Mg2+, Ca2+) twice and fresh medium was added, containing the respective 
compounds/inhibitors in various concentrations. Controls contained the respective DMSO 
concentrations. As an additional controls, starvation medium (pure DMEM) and pure 
ECGM medium without DMSO was applied to the cells. For each treatment, the scratch 
width of three individual wells was quantified after 16 hours of incubation according to a 
published protocol (Liang, Park, and Guan 2007). 
 
5.2.3 Lithography 
5.2.3.1 Master wafer production 
Master wafer production of the intended micro patterns was prepared on silicone using 
photolithography under clean room conditions. An adhesion promoter (TI-Prime) was spin-
coated onto a silicon wafer (Si-Mat), firstly by cebtrifugation at 500 rpm for 5 seconds and 
subsequently 5000 rpm for 30 seconds. Next, the wafer was heated for 2 minutes at 
120°C on a hot plate. Subsequently, 15 µm thick layer of negative photoresist SU-8 100 
was applied by spin-coating firstly at 500 rpm for 5 seconds and then accelerating the 
centrifugation speed to 2000 rpm for 35 seconds. After soft-baking the wafer at 65°C for 
2 minutes and then at 95°C for 5 minutes, the wafer was exposed to UV-light (spectral 
lines at 365 nm, 405 nm, 436 nm) through a photo mask (purchased at Zitzmann GmbH) 
of the intended pattern. Alternatively, a laser lithography device was used to write the 
desired pattern directly into the photoresist. After exposure, an additional baking step was 
performed at 95 °C in order to selectively crosslink the UV-exposed portions of the resist. 
Subsequently, the wafer was placed in the developer solution mr-Dev 600 for 
approximately 2 minutes. To inhibit crack formation in the photoresist layer, the wafer was 
heated again for 5 minutes at 95 °C. Finally, the surface was silanized with 
per-fluoro-tri-chlorosilane by evaporation and then coated with PDMS as described in the 
next section. 
 
5.2.3.2 Micro contact printing 
Silicon masters were covered with Sylgard silicone elastomere 184 (=PDMS) in a 1:10 
ratio, and PDMS (=poly dimethyl siloxane) was allowed to polymerize overnight at 60 °C 
after vacuum-based removal of air bubbles. PDMS stamps were cut out from the silicon 
wafer and treated in a PSD-UV ozone/UV-cleaner for 20 minutes. Subsequently, PDMS 
stamps were incubated in a protein solution containing 50 µg/ml fibronectin. After 2 hours 
of incubation, stamps were removed from the protein solution, washed twice with ultrapure 
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water, and left in laminar flow for drying. Eight to ten minutes later, stamps were 
completely dry and ready for further use. 8-well slides were pre-treated with UV/Ozone for 
8 minutes and PDMS stamps were positioned into a well with the structured side facing 
the surface. For proper protein transfer, the stamp was left on the surface for 1 hour. 
Subsequently, the non-adhesive regions were passivated with 1 mg/ml PLL-(2)-PEG 
(Poly-L-lysine-(2)-poly ethylene glycol) diluted in PBS for 20 min. Before cell seeding, 
wells were washed twice with PBS in order to remove unbound PLL-(2)-PEG. 
 
5.2.4 Immunofluorescence staining 
5.2.4.1 Staining on surfaces  
Immunofluorescence stainings in 1D and 2D settings were performed in identical 
experimental procedures. 20 hours after cell seeding, cells were washed twice with pre-
warmed PBS. Subsequently, cells were fixated with 4 % pFA for 10 minutes. After an 
additional washing step with PBS, cells were permeabilized for 10 minutes using 0.2 % 
Triton X-100 in PBS. Prior to staining procedure, samples were blocked with 1 % BSA in 
PBS for 30 minutes. Subsequently, primary antibodies were added, diluted in PBS 
containing 1 % BSA. After incubation at 4 °C over night, samples were washed three 
times with PBS containing 0.2 % BSA. Then secondary antibodies, as well as 0.5 µg/ml 
Hoechst 33342 1:400 rhodamine-phalloidin were diluted in PBS + 0.2 % BSA and added 
to the wells. After 30 minutes, cells were washed three times with PBS + 0.2 % BSA for 
5 minutes and covered with Save Flour Reagent and a coverslip. 
 
5.2.4.2 Staining in Collagen I gels 
HUVEC in Collagen I gels were fixed with 4 % pFA for 40 minutes and washed with PBS 
twice for 20 min each time. Subsequently, cells were permeabilized for 20 minutes using 
0.5 % Triton X-100 in PBS. Then, samples were washed with PBS for 30 minutes and 
blocked with 1 % BSA in PBS overnight. Primary antibodies were diluted to the intended 
concentrations in PBS/1 % BSA. Staining solution was filled in both reservoirs and 
incubated at 4 °C for 72 hours. After incubation, samples were washed twice with PBS for 
30 minutes and secondary antibodies were added in the appropriate concentrations for 
48 hours. In general, applied primary and secondary antibody concentrations were twice 
as high as for 1D and 2D immuno-stainings Subsequently, gels were washed twice with 
PBS for 30 minutes and stained for 40 min with 0.5 µg/ml Hoechst 33342 and 
rhodamine-phalloidin, diluted 1:400 in PBS. Subsequently samples were washed again for 
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30 minutes with PBS. For immuno-stainings of collagen I in collagen gels, gels were fixed 
with 0.2 % glutaraldehyde instead of 4 % pFA 
 
5.2.4.3 Tubulin washout 
20 hours after seeding HUVECs in an 8-well slide, cells were washed twice with 
PBS (+ Ca2+/Mg2+). Monomeric tubulin was extracted by adding 270 µl cell extraction 
buffer into each well. After 10 seconds, samples were fixed by adding 0.5 % 
glutaraldehyde to the cell extraction buffer for 10 minutes. Subsequently, 270 µl of 0.1 % 
NaBH4 solution was added for 7 min, in order to quench the auto-fluorescence of 
glutaraldehyde. Subsequent immune-staining was performed as described in section 
5.2.4.1.  
 
5.2.5 Microscopy 
5.2.5.1 Laser scanning confocal microscopy 
Laser scanning confocal microscopy was performed using a Leica SP8 LSM microscope. 
Pinhole size was at 1.0 airy unit for all experiments. The following excitation laser wave 
lengths were used: 405 nm, 488 nm, 561 nm, 647 nm. The detectors were individually 
adjusted to the specific spectrums of the fluorescence dyes. To avoid cross-talk between 
the channels only sequential scans of single channels were made in all experiments. In 
order to reduce background noise, an average of four frames was obtained for every 
channel. Scanning frequency was at 400 Hz for most of the experiments. For fast cellular 
processes scan frequency was set to 1400 Hz or to 7000 Hz (resonance scanner). 
Objectives used in this study: 63x oil, 40x oil, 63x water, 20x multi immersion, 10x air. 
Images used for densitometry analysis, were recorded with a consistent resolution 
(usually 1024 x 1024 pixels), detector gain, laser intensity and zoom factor. Moreover, 
lasers were pre-warmed for at least 1 hour to avoid changes in signal intensity over time. 
To avoid information loss due to over exposure, images were checked for local signal 
intensities with false color transformation.  
 
5.2.5.2 Wide field microscopy 
Wide field microscopy was performed using a Nikon Ti Eclipse inverted microscope. 
Fluorescence microscopy was performed using preset excitation and extinction filter sets 
for the corresponding wavelength.  
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5.2.5.3 Live cell imaging 
Live cell imaging with the LSM SP8 confocal microscope was performed using an Okolab 
bold line incubation system. For the Nikon Ti Eclipse, a complete incubation system from 
Ibidi was used. Cells were kept under 37 °C, 80 % humidity and 5 % CO2 during the entire 
experiment.  
 
5.2.6 Protein-biochemical methods 
5.2.6.1 Preparation of lysates 
24 hours after treatment, cells were washed once with ice-cold PBS. For 6 well plates, 
180 µl of lysis buffer was added to each well and cells were frozen at -80 °C for at least 
20 minutes. Lysates were thawed on ice and transferred into reaction tubes. 
Subsequently, lysates were centrifuged for 10 minutes at 4 °C and 14.000 rpm. 5 µl of the 
supernatant were used to determine the protein content with a Bradford protein assay. 
The residual samples were mixed with 5x sample buffer, and heated to 95 °C for 
5 minutes. Samples were kept frozen at -20 °C until further usage. 
 
5.2.6.2 Bradford assay 
Bradford assay was performed in a 96-well plate format. Protein samples and BSA 
standards were mixed with 1x Bradford solution in triplicates and incubated on a shaker 
for 5 minutes. Subsequently, samples were measured using a plate reader and protein 
concentration of the samples was determined by extrapolation to a BSA standard solution. 
 
5.2.6.3 SDS-PAGE 
Prior to experiment, samples were adjusted to the same protein concentration using 1x 
sample buffer. SDS-PAGE (sodium dodecyl sulfate polyacrylamide gel electrophoresis) 
was performed using 10 % or 12 % polyacrylamide gels. 40 µl of each sample was loaded 
in the pockets of the gel and electrophoresis was performed in running buffer at a 
constant voltage of 100 V for 1 hour. 
 
5.2.6.4 Western Blot analysis 
Proteins were transferred using a wet blotting system. Nitrocellulose membranes were cut 
to adequate size and equilibrated in tank buffer for at least 20 minutes. Protein transfer 
was performed at 100 V for 1.5 hours. Subsequently, the membrane was blocked with 
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5 % Blotto for 2 hours at RT and primary antibodies were added at 4°C over night. After 
washing four times with PBS-T under agitation, HRP-coupled secondary antibodies were 
added and the membrane was incubated for 2 hours at RT. Unbound antibodies were 
removed by washing the membrane four times with PBS-T. Photo sensitive films were 
developed using an Agfa Curix 60 developer after 1 minute incubation with Amersham 
ECL reagent. 
 
5.2.6.5 Protein labeling 
Protein labeling of fibronectin was performed using an antibody labeling kit from pierce 
(DyLight488). A volume of 500 µl with a fibronectin concentration of 2 mg/ml (in H2O 
supplemented with borate puffer obtained from the kit) was added to the vial containing 
the dye for 60 min under light exclusion. Subsequently, labeled proteins were purified 
according to the manufacturer’s instructions. Finally, labeled protein concentration was 
determined using a Nano Drop device.  
 
5.2.7 Molecular biological methods 
5.2.7.1 E.coli cultivation 
Escherichia coli bacteria were cultivated in liquid LB-Medium under strong agitation or on 
LB containing agar plate at 37 °C. For selection 50 µg/ml ampicillin or kanamycin was 
added depending on the bacterial resistance on the respective plasmid. 
 
5.2.7.2 Transformation 
100 µl of competent E.coli cells (DH5αF strain) were thawed on ice and mixed carefully 
with 0.5 – 1.5 µl DNA (depending on DNA concentration and quality). Bacteria were 
incubated on ice for 30 minutes and heat-shocked at 42 °C for 1 minute and 15 seconds. 
After an additional incubation time on ice for 2 min, bacteria were plated on LB plates 
(containing the respective antibiotics) and incubated at 37 °C overnight. On the next day a 
single colony was picked with a sterile pipette tip and transferred into LB-medium for 
plasmid preparation.  
 
5.2.7.3 Plasmid preparation 
Plasmid preparation was performed using a Quiagen Maxi Preparation Kit according to 
manufacturer` instructions. Final plasmid concentration was determined using a Nano 
Drop device.  
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5.2.8 Theoretical methods 
5.2.8.1 Image and movie processing 
Image and movie processing was performed using the open source software ImageJ or 
Fiji. Figures were made using the open source vector based graphic program Inkscape.  
 
5.2.8.2 Statistical analysis 
Statistical analysis was performed using GraphPad Prism.  
 
5.2.8.3 Densitometry analysis 
Densitometry analysis was performed using the open source software ImageJ. Images 
were converted into 8-bit greyscale images and pixel intensity was quantified using the 
measure tool. For comparison of different regions always a same sized region of interest 
was chosen.  
 
5.2.8.4 Analysis of length and shapes 
Measurement of length and shapes was performed using ImageJ or the Leica related 
program LAS X. In ImageJ, pixel size was adjusted using the information provided by the 
microscope associated programs LAS X or NIS-elements.  
 
5.2.8.5 Analysis of mean velocity 
Mean velocity of cell trajectories was determined using the open source software 
chemotaxis & migration tool from Ibidi according to the manufacturers’ instructions. Pixel 
size information for coordinate transformation was taken from the microscope associated 
programs LAS X or NIS-elements. 
 
5.2.8.6 Analysis of Directionality 
Directionality of cell trajectories was determined using the open source software 
chemotaxis & migration tool from Ibidi according to the manufacturers’ instructions. Pixel 
size information for coordinate transformation was taken from the microscope associated 
programs LAS X or NIS-elements. 
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5.2.8.7 Change point (bimodal) analysis of migration tracks 
The bimodal analysis was performed in cooperation with Felix Segerer, Christoph 
Schreiber and Joachim Rädler of the physics department of the LMU Munich. 
In order to evaluate the transition points between the two different migration regimes (run 
and rest states), we implemented an iterative change point analysis based on classical 
cumulative sum (CUSUM) statistics in combination with a motion classification via a fit on 
the mean squared displacement (MSD).  
To this end, in order to find characteristic changes in the cellular motion pattern, we first 
calculated the CUSUM of the velocity 𝑣(𝑡) (i.e. the moving distance between two 
consecutive frames divided by the time period between two frames within a track) for 
each time t within a track. 
𝑆𝑡 = ∑(𝑣𝑖 − ?̅?)
𝑡
𝑖=1
 
Here, ?̅? denotes the average velocity within the tracking interval t = 0,…,T. To evaluate 
whether a change point occurred within the interval, we estimate a confidence level for 
the change point existence via a bootstrap analysis. Therefore, we define the estimator 
for the magnitude of the change as 
𝑆𝑑𝑖𝑓𝑓 = ( max
𝑡=0,…,𝑇
𝑆𝑡) − ( min
𝑡=0,…,𝑇
𝑆𝑡) 
 
which is calculated for the actually measured velocity CUSUM as well as for a set of 
bootstrapped CUSUMs where the consecutive order of 𝑣𝑡 ∶  −  𝑡 ∈ {0, … , 𝑇} is permutated 
randomly. The confidence level for at least one change point occurrence within the 
interval is now calculated as: 
𝐿𝑐𝑜𝑛𝑓 =
𝑁(𝑆𝑑𝑖𝑓𝑓<𝑆𝑑𝑖𝑓𝑓
0 )
𝑁𝑝𝑒𝑟𝑚
   
Here 𝑁(𝑆𝑑𝑖𝑓𝑓<𝑆𝑑𝑖𝑓𝑓
0 ) denotes the number of bootstrap CUSUMs for which 𝑆𝑑𝑖𝑓𝑓 is smaller 
than the estimator of the original CUSUM 𝑆𝑑𝑖𝑓𝑓
0  and 𝑁𝑝𝑒𝑟𝑚denotes the total number of 
bootstrap samples. If not denoted otherwise, 𝑁𝑝𝑒𝑟𝑚 = 10000 was chosen. If 𝐿𝑐𝑜𝑛𝑓 is 
above a certain threshold level 𝐿𝑡ℎ we evaluated the position of the change point via the 
CUSUM estimator: 
𝑆𝐶𝑃 = max
𝑡=0,…,𝑇
| 𝑆𝑡| 
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As a trade-off between accuracy and liability to small fluctuation in cell motion, 𝐿𝑡ℎ =
0.7 was chosen. If a change point was detected with confidence 𝐿𝑐𝑜𝑛𝑓 > 𝐿𝑡ℎ, this 
procedure was repeated iteratively for the two resulting intervals adjacent to the change 
point until no further change points with a confidence level 𝐿𝑐𝑜𝑛𝑓 > 𝐿𝑡ℎ were detected. 
In the next step, to determine if an interval is part of the running or resting period of a 
cell, the time averaged MSD was calculated for each interval between two consecutive 
change points via: 
𝑀𝑆𝐷(𝑡) =
1
𝑇 − 𝑡 + 1
∑[𝜑(𝜏 + 𝑡) − 𝜑(𝜏)]2
𝑇−𝑡
𝜏=0
 
 
The MSD was now fitted by a fitting function (𝑡) = 𝑎 ⋅ 𝑡𝑏 , were the fitting exponent 𝑏 
indicates whether a motion pattern shows normal (𝑏 = 1) or anomalous diffusion (𝑏 ≠ 1). 
Here, a value of 𝑏 = 2 would correspond to ballistic motion. In order to dissect periods 
where the cells show directional persistent motion, a threshold of 𝑏𝑡ℎ = 1.75 was chosen, 
classifying all intervals where 𝑏 < 𝑏𝑡ℎ as non ballistic and therefore rest states and all 
intervals where 𝑏 > 𝑏𝑡ℎ as ballistic and consequently run state periods. Note that for very 
short intervals (T< 60min), were only a very limited set of data points is accessible, the fit 
of the MSD is not a very robust measure. Hence for such short intervals, the criterion such 
that if 𝑣𝑡 is strictly increasing or decreasing within the interval was chosen, the interval 
was considered a run state, while it was considered a rest state if this condition is not met. 
Finally, all change points between two rest state periods or two run state periods going in 
the same direction were removed. 
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7. Appendix 
 
7.1 Movie descriptions 
Movies are on the compact disc attached to this thesis.  
 
Movie S1 HUVEC migrating straight over a 3 µm wide micro-track without changing 
direction.  
Movie S2 HUVEC migrating over a 3 µm wide micro-track, with frequent changes of 
directions. During contraction and reorientation, the cell starts to bleb at the whole cell 
body. 
Movie S3 HUVEC on a 3 µm wide micro-track transfected with LifeAct-RFP (displayed in 
red) and Cortactin-GFP (displayed in green). Cell is in a lamellipodium-based migration 
mode without displaying membrane blebs. 
Movie S4 HUVEC on a 3 µm wide micro-track transfected with LifeAct-RFP (displayed in 
red) and Cortactin-GFP (displayed in green). Cell is in a phase of contraction and 
reorientation and displays pronounced membrane blebs. 
Movie S5 HUVEC migrating on a planar 2D, fibronectin coated plastic surface. Cell was 
treated with 10 µM Blebbistatin. 
Movie S6 HUVECs migrating on a planar 2D, fibronectin coated plastic surface 
Movie S7 HUVEC migrating in collagen gel switches between morphological modes. 
Movie S8 HUVEC migrating in a collagen I gel after Blebbistatin treatment (10 µM). 
MovieS9 HUVEC migrating in a collagen I gel after Calyculin A treatment (500 pM). 
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7.4 Abbreviations 
 
µl Microliter 
µM Micromolar 
µm Micrometer 
1D One dimensional 
2D Two dimensional 
3D Three Dimensional 
ATP Adenosine triphosphate 
BSA Bovine serum albumin 
CAM Chorio-allantoic membrane 
CTRL Control 
Cyto D Cytochalasin D 
DBZ Dibenzazepine 
DLL4 Delta like ligand 4 
DMSO Dimethyl sulfoxide 
DNA Desoxy ribonucleotid acid 
EC Endothelial cell 
ECBM Endothelial basal medium 
ECGM Endothelial growth medium 
ECM Extracellular matrix 
ELC Essential light chain 
EMT Epithelial mesenchymal transition 
EPC Endothelial progenitor cell 
FCS Fetal calf serum 
GAF GTPase activating protein 
GEF Guanine nucleotide exchange factor 
HIF Hypoxia inducible factor 
HUVEC Human umbilical vein endothelial cells 
kDA Kilo Dalton 
LB Lysogeny broth 
M Molar 
MAPK Mitogen activated protein kinase 
ml Milliliter 
MLC Myosin light chain 
MLCK Myosin light chain kinase 
MLCP Myosin light chain phosphatase 
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mM Millimolar 
MRTF Myocardin related transcription factor 
MT Micotubule 
NICD Notch intracellular domain 
nM Nanomolar 
nm Nanometer 
NO  Nitric oxide 
Noco Nocodazole 
PBS Phosphate buffered saline 
PDMS Poly dimethyl siloxane 
pFA Para formaldehyde 
PKB Protein kinase B 
PLGF Placenta growth factor 
PLL-PEG Poly-L-lysine poly ethylene glycol 
pM Pico molar 
RLC Regulatory light chain 
ROCK Rho associated kinase 
Rpm Rotations per minute 
RT Room temperature 
SC Stalk Cell 
SDS Sodium dodecyl sulfate 
SEM Standard error of the mean 
Ser Serin 
siRNA Short interference ribonucleotide acid 
TC Tip Cell 
Thr Threonin 
VEGF Vascular endothelial growth factor 
VEGFR Vascular endothelial growth factor receptor 
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